Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MS10 - Lung Cancer Screening, Opportunistic Evaluation of Findings
- 15:45 - 17:15
- 9/09/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Screening and Early Detection
- Moderators:Dorith Shaham, Eduard Monsó
-
+
MS10.01 - COPD/Emphysema
15:45 - 15:55 | Presenter: Javier Zulueta
- Abstract
Loading... -
+
MS10.02 - Coronary Artery Diseases
15:55 - 16:05 | Presenter: Joseph Shemesh
- Abstract
Loading... -
+
MS10.03 - Aortic Valve Calcifications
16:05 - 16:15 | Presenter: Yeqing Zhu | Author(s): Yong Wang, William Gioia, Rowena Yip, Artit Jirapatnakul, Micheal Chung, David Yankelevitz, Claudia I Henschke
- Abstract
Loading... -
+
MS10.04 - Liver - Pulmonary Disease
16:15 - 16:25 | Presenter: Andrea D Branch
- Abstract
Loading... -
+
MS10.05 - Osteoporosis
16:25 - 16:35 | Presenter: Jessica Gonzalez-Gutierrez
- Abstract
No abstract available for this presentation
-
+
MS10.06 - Interstitial Lung Diseases
16:35 - 16:45 | Presenter: Mary Salvatore
- Abstract
Loading... -
+
MS10.07 - Breast Evaluation
16:45 - 16:55 | Presenter: Laurie Margolies
- Abstract
Loading... -
+
MS10.08 - Q&A
16:55 - 17:15
- Abstract
No abstract available for this presentation
-
+
MS11 - Addressing Challenges with Surgical Resection of Lung Cancer
- 15:45 - 17:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Moderators:Ramon Rami-Porta, Haruhiko Kondo
-
+
Introduction/Poll - MS11.01
15:45 - 15:45
- Abstract
No abstract available for this presentation
-
+
Introduction/Poll - MS11.02
16:00 - 16:00
- Abstract
No abstract available for this presentation
-
+
Introduction/Poll - MS11.03
16:15 - 16:15
- Abstract
No abstract available for this presentation
-
+
Introduction/Poll - MS11.04
16:30 - 16:30
- Abstract
No abstract available for this presentation
-
+
Introduction/Poll - MS11.05
16:45 - 16:45
- Abstract
No abstract available for this presentation
-
+
MS11.01 - Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiation for Potentially Resectable Nsclc - a Surgeon's Perspective
15:45 - 16:00 | Presenter: Ricardo Mingarini Terra
- Abstract
Loading... -
+
MS11.02 - Role of Surgery in Oligometastatic NSCLC
16:00 - 16:15 | Presenter: C S Pramesh
- Abstract
Loading... -
+
MS11.03 - Minimizing Peri-Operative Morbidity with Pneumonectomy
16:15 - 16:30 | Presenter: Shun-ichi Watanabe
- Abstract
Loading... -
+
MS11.04 - Surgical Resection of SCLC - Not so Obsolete Any Longer
16:30 - 16:45 | Presenter: Gustavo Lyons
- Abstract
Loading... -
+
MS11.05 - Pathological Reporting of Resected Lung Cancer - the Importance of Using Additional TNM Descriptors
16:45 - 17:00 | Presenter: Ellen Caroline Toledo Nascimento
- Abstract
Loading... -
+
MS11.06 - The Impact of Prehabilitation on Patients Having Lung Cancer Surgery
17:00 - 17:15 | Presenter: David Sanchez-Lorente
- Abstract
No abstract available for this presentation
-
+
MS11.07 - Q&A
17:15 - 17:30
- Abstract
No abstract available for this presentation
-
+
OA12 - Profiling the Multidisciplinary Management of Stage III NSCLC
- 15:45 - 17:15
- 9/09/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Dirk De Ruysscher, Bartomeu Massuti
-
+
OA12.01 - PCI for Radically Treated Non-Small Cell Lung Cancer: A Meta-Analysis Using Updated Individual Patient Data of Randomized Trials
15:45 - 15:55 | Presenter: Willem Witlox | Author(s): Dirk De Ruysscher, Benjamin Lacas, Cecile Le Pechoux, Jean-Pierre Pignon, Matthias Guckenberger, Alexander Sun, Mary Redman, Si-Yu Wang, Chen Hu, Vincent Van Der Noort, Ning Li, Harm Van Tinteren, Harry JM Groen, Manuela Joore, Bram Ramaekers
- Abstract
Loading... -
+
OA12.02 - Randomized Phase II Study of CDDP+S-1 vs CDDP+PEM Combined with Thoracic RT for Locally Advanced Non-Sq NSCLC: SPECTRA Study
15:55 - 16:05 | Presenter: Takashi Seto | Author(s): Seiji Niho, Tatsuya Yoshida, Tetsuo Akimoto, Kentaro Sakamaki, Akira Ono, Makoto Nishio, Noboru Yamamoto, Toyoaki Hida, Hiroaki Okamoto, Takayasu Kurata, Yoshihiro Hattori, Koichi Goto, Takeharu Yamanaka, Yuichiro Ohe
- Abstract
Loading... -
+
OA12.03 - Initial Reporting of NRG-LU001, Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC
16:05 - 16:15 | Presenter: Heath Skinner | Author(s): Chen Hu, Theodoros Tsakiridis, Rafael Santana-Davila, Bo Lu, Jeremy Erasmus, Anthony Doemer, Gregory Videtic, James Coster, Alex Xuexhong Yang, Richard Lee, Maria Werner Wasik, Phillip Schaner, Steven McCormack, Benjamin Esparaz, Rondal McGarry, Jose Bazan, Timothy Stuve, Jeffrey D Bradley
- Abstract
Loading... -
+
OA12.04 - Discussant - OA12.01, OA12.02, OA12.03
16:15 - 16:25 | Presenter: Everett E. Vokes
- Abstract
No abstract available for this presentation
-
+
OA12.05 - Imaging-Guided Target Volume Reduction in Radiotherapy of Lung Cancer: The Prospective Randomized Multinational PET-Plan Trial
16:25 - 16:35 | Presenter: Eleni Gkika | Author(s): Ursula Nestle, Tanja Schimek-Jasch, Stephanie Kremp, Andrea Schaefer, Andreas Kuesters, Marco Tosch, Thomas Hehr, Martina Eschmann, Yves-Pierre Bultel, Peter Hass, Jochen Fleckenstein, Alexander Thieme, Marcus Stockinger, Matthias Miederer, Gabriele Holl, Christian Rischke, Sonja Adebahr, Jochem Koenig, Anca-Ligia Grosu
- Abstract
Loading... -
+
OA12.06 - A Prospective Randomized Phase Ⅲ Study of Precise PORT for Patients with pⅢA-N2 NSCLC After Complete Resection and Adjuvant Chemotherapy
16:35 - 16:45 | Presenter: Zhouguang Hui | Author(s): Yu Men, Chen Hu, zongmei Zhou, Jun Liang, qinfu Feng, Bi Nan, Xin Wang, Dongfu Chen, zefen Xiao, Jima Lv, Lei Deng, Tao Zhang, wenqing Wang, Shugeng Gao, Jie He, Luhua Wang
- Abstract
Loading... -
+
OA12.07 - Radicality of Lymphadenectomy in Lung Cancer According to Surgical Approach. Results from the Spanish Group of Video-Assisted Thoracic Surgery
16:45 - 16:55 | Presenter: Carme Obiols | Author(s): Sergi Call, Ramon Rami-Porta, Angeles Jaen, David Gomez De Antonio, Silvana Crowley, Iñigo Royo, Raúl Embún
- Abstract
Loading... -
+
OA12.08 - Discussant - OA12.05, OA12.06, OA12.07
16:55 - 17:05 | Presenter: José Belderbos
- Abstract
No abstract available for this presentation
-
+
OA12.09 - James D. Cox Lectureship Award for Radiation Oncology
17:05 - 17:15 | Presenter: Corinne Faivre-Finn
- Abstract
No abstract available for this presentation
-
+
PC03 - Adjuvant Therapy for Resected NSCLC Harboring EGFR Mutation, Chemotherapy or Targeted Therapy
- 15:45 - 17:15
- 9/09/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Pro-Con Session
- Track: Targeted Therapy
- Moderators:James Chih-Hsin Yang, Elisa Gobbini
-
+
PC03.01 - PROs
15:45 - 16:05 | Presenter: Wen-Zhao Zhong
- Abstract
Loading... -
+
PC03.02 - CONs
16:05 - 16:25 | Presenter: Jyoti D Patel
- Abstract
Loading... -
+
PC03.03 - Future Strategies in Early Stage EGFR-mut NSCLC
16:25 - 16:45 | Presenter: Vassiliki A Papadimitrakopoulou
- Abstract
Loading... -
+
PC03.04 - Q&A
16:45 - 17:15
- Abstract
No abstract available for this presentation
-
+
WS05 - Staging Workshop Part 2: The Importance of Invasive Nodal Staging in Thoracic Malignancies
- 15:45 - 17:15
- 9/09/2019
- Location: San Francisco (2009)
- IASLC CME Accredited
- Type: Workshop
- Track: Staging
- Moderators:Jose Maria Matilla, Ricardo Beyruti
-
+
Introduction/Poll
15:45 - 16:00
- Abstract
No abstract available for this presentation
-
+
WS05.01 - Invasive Pre-Operative Staging of Lung Cancer
16:00 - 16:10 | Presenter: Sergi Call
- Abstract
Loading... -
+
WS05.02 - "Loge De Baréty": What and Where It Is and Its Relation with the IASLC Lymph Node Map
16:10 - 16:20 | Presenter: Francoise Le Pimpec-Barthes
- Abstract
No abstract available for this presentation
-
+
WS05.03 - How to Perform a Proper Systematic Nodal Dissection in Lung Cancer Surgery
16:20 - 16:30 | Presenter: Kyohei Masai | Author(s): Kaoru Kaseda, Keisuke Asakura, Tomoyuki Hishida, Hisao Asamura
- Abstract
Loading... -
+
WS05.04 - Particularities of Lymphadenectomy in Malignant Pleural Mesothelioma
16:30 - 16:40 | Presenter: Andrea Bille
- Abstract
Loading... -
+
WS05.05 - Lymphnode Dissection in Thymic Malignancies: Implications of the ITMIG/IASLC Lymph Node Map of the Tnm Classification and Staging
16:40 - 16:50 | Presenter: Young Tae Kim | Author(s): In Kyu Park
- Abstract
Loading... -
+
WS05.06 - Relevance of Lymphadenectomy in Carcinoma of the Esophagus and of the Esophagogastric Junction
16:50 - 17:00 | Presenter: Gail Darling
- Abstract
Loading... -
+
WS05.07 - Q&A/Poll
17:00 - 17:15
- Abstract
No abstract available for this presentation
-
+
IS15 - Symposium by Medscape: Immune Checkpoint Inhibitor Treatment for Frontline Metastatic NSCLC: The Evolving Role of Biomarkers in Guiding Decisions
- 18:15 - 19:45
- 9/09/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-01 - Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 ≥50%
10:15 - 10:15 | Presenter: Sue Lee | Author(s): Ahmet Sezer, Miranda Gogishvili, Dmitry Bentsion, Saadettin Kilickap, Anna Lowczak, Mahmut Gumus, Oleg Gladkov, Philip Clingan, Virote Sriuranpong, Naiyer A Rizvi, Siyu Li, Pamela Snodgrass, Mark Navarro, Israel Lowy, Petra Rietschel
- Abstract
Loading... -
+
P2.01-02 - CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
10:15 - 10:15 | Presenter: Edward Garon | Author(s): Andrea Ardizzoni, Fabrice Barlesi, Byoung Chul Cho, Pedro De Marchi, Yasushi Goto, Shun Lu, Luis Paz-Ares, David R Spigel, Michael Thomas, Bijoyesh Mookerjee, Pilar Cazorla Arratia, Jason Baum, Zhu Zewen, James Chih-Hsin Yang
- Abstract
Loading... -
+
P2.01-03 - Tumor Treating Fields Plus Standard of Care Treatment in Stage 4 Non-Small Cell Lung Cancer (NSCLC): Phase 3 LUNAR Study
10:15 - 10:15 | Presenter: Uri Weinberg | Author(s): Ori Farber, Moshe Giladi, Zeev Bomzon, Eilon D Kirson
- Abstract
Loading... -
+
P2.01-04 - NCI-NRG Oncology ALK PROTOCOL (NRG-LU003): A Biomarker-Driven Protocol for Previously Treated ALK-Positive Non-Squamous NSCLC Patients
10:15 - 10:15 | Presenter: Shakun Malik | Author(s): Chen Hu, Alice T. Shaw, Edward Korn, Anne Tsao, Robert C. Doebele, Thomas Stinchcombe, Christine M Lovly, Jeffery D. Bradley
- Abstract
Loading... -
+
P2.01-05 - MAGELLAN: Phase 1B Study of Durvalumab with Novel Oncology Therapies, With/Without Chemotherapy, in Untreated Stage IV NSCLC
10:15 - 10:15 | Presenter: Sandip Pravin Patel | Author(s): Yufan Liu, Ellie Grainger, Zeshaan Rasheed, Teresa Improta
- Abstract
Loading... -
+
P2.01-06 - Phase I Study of Nivolumab and Ipilimumab Combined with Nintedanib in Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Jhanelle Elaine Gray | Author(s): Sonam Puri, Noemi E Rodriguez Guadalupe, Sandrine Niyongere, Theresa A Boyle, Ram Thapa, Dung-Tsa Chen, David Noyes, Monica S Chatwal, Scott J. Antonia
- Abstract
Loading... -
+
P2.01-07 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1-Containing Therapy (HUDSON)
10:15 - 10:15 | Presenter: Si-Houy Lao-Sirieix | Author(s): John Victor Heymach, Patrick M. Forde, Michael Thomas, Keunchil Park, Benjamin Besse, Mark Awad, Glenwood D. Goss, Naiyer A Rizvi, Helen A Ambrose, Wouter Hanekom, Steven Fox, Philip J Jewsbury, Gayle P Pouliot, Peter G Mortimer, Sabina I Patel, Kris Sachsenmeier, J.C Barrett, M Stuart, Z Szucs, L Walton
- Abstract
Loading... -
+
P2.01-08 - Clinical Trial in Progress: CONCORDE - A Phase 1B Study of Novel Agents in Combination with Conventional Radiotherapy in NSCLC
10:15 - 10:15 | Presenter: Andrew Michael Hudson | Author(s): Sarah Brown, Anthony Chalmers, Caroline Dive, Kevin Franks, Gerard G Hanna, Nicola Hannaway, Stephen Harrow, Tom Haswell, Crispin Hiley, Samantha Hinsley, Matthew G Krebs, Geraldine Murden, Sadie Reed, Anderson Ryan, David Sebag-Montefiore, Paul Shaw, Alexandra Smith, Gerard Walls, Robin Young, Corinne Faivre-Finn, Alastair Greystoke
- Abstract
Loading... -
+
P2.01-09 - VinMetAtezo: Phase II Trial of Metronomic Oral Vinorelbine with Atezolizumab for Recurrent Stage IV NSCLC (GFPC*04-08)
10:15 - 10:15 | Presenter: Alain Vergnenegre | Author(s): Gilles Robinet, Christos Chouaid, acya Bizieux, Isabelle Monnet, Charles Ricordel
- Abstract
Loading... -
+
P2.01-10 - Real Clinical Practice Study to Evaluate 2 Line Treatment Based on Comprenhensive Genomic Profiling in NSCLC. LungONE Study
10:15 - 10:15 | Presenter: Javier De Castro Carpeno | Author(s): Enriqueta Felip, Oscar Juan, Rosario Garcia Campelo, David Aguiar, Josefa Terrassa, Rafael Lopez Castro, Antonio Calles Blanco, Alfredo Paredes, Reyes Bernabe, Isidoro Barneto, Juana Campillo, Luis García-Palacios, Federico Rojo
- Abstract
Loading... -
+
P2.01-100 - Spectrum of EGFR Exon 20 Insertion Mutations and Co-Occurring Genetic Alterations in Patients with Non-Small-Cell Lung Cancer
10:15 - 10:15 | Presenter: Gabriela Liliana Bravo Montenegro | Author(s): Misako Nagasaka, Patrick Chi-Chung Ma, abdul rafeh Naqash, Hirva Mamdani, Alexander Spira, Deepa S Subramaniam, Rebecca Feldman, Chul Kim
- Abstract
Loading... -
+
P2.01-101 - Multiple Chemotherapy-Based Combination Therapy Strategies for Advanced Lung Cancer Patients: A Systematic Review and Network Meta-Analysis
10:15 - 10:15 | Presenter: Hexiao Tang | Author(s): Lecai Xiong, Yuquan Bai, Jinping Zhao, Michael Lanuti
- Abstract
Loading... -
+
P2.01-102 - Outcome of Patients with EGFR Exon 19 Mutation in a Phase III Randomized Trial Comparing Gefitinib to Gefitinib with Chemotherapy
10:15 - 10:15 | Presenter: Kumar Prabhash | Author(s): Vanita Noronha, Vijay Maruti Patil, Amit Joshi, Anuradha Chougule, Abhishek Mahajan, Amit Janu, Rajiv Kumar, Sucheta More, Supriya Goud, Nandkumar Kumar, Nilesh Daware, Atanu Bhattacherjee, Srushti Shah, Akansha Yadav, Shripad D Banavali
- Abstract
Loading... -
+
P2.01-103 - Real-World Treatment Patterns and Survival in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
10:15 - 10:15 | Presenter: Sai-Hong I Ou | Author(s): Maral Dersarkissian, Rachel Bhak, Huamao M Lin, Shuanglian Li, Mu Cheng, Angie Lax, Hui Huang, Mei Sheng Duh
- Abstract
Loading... -
+
P2.01-11 - ALKternate: A Proof of Concept Study in ALK-Rearranged NSCLC Alternating Lorlatinib with Crizotinib After Disease Progression
10:15 - 10:15 | Presenter: Malinda Itchins | Author(s): Sarah A Hayes, Amanda L Hudson, Viive M Howell, Shao Weng Daniel Tan, Stephen Clarke, Benjamin J Solomon, Nick Pavlakis
- Abstract
Loading... -
+
P2.01-12 - A Phase I/II Trial of IO102 and Pembrolizumab With/Without Chemotherapy as First-line Treatment of Metastatic NSCLC
10:15 - 10:15 | Presenter: Mariano Provencio | Author(s): James Spicer, Pilar Garrido, Jose Manuel Trigo Perez, Santiago Viteri, Joaquim Bosch-Barrera, Amelia Insa, Enriqueta Felip, Javier De Castro Carpeno, Elisabeth Coart, Emmett Schmidt, Anita Vedel Christiansen, Mads Hald Andersen, Mai-Britt Zocca, Eva Ehrnrooth, Luis Paz-Aras
- Abstract
Loading... -
+
P2.01-13 - The DAIL Trial: Dietetic Assessment and Intervention in Lung Cancer
10:15 - 10:15 | Presenter: Veni Ezil | Author(s): iain Phillips, Adele Hug, Lindsey Allan, Naomi Westran, Madeleine Hewish, Ajay Mehta, Laurensius Mainsiouw, Alice Extance, Bing Smith, Helen Saxby
- Abstract
Loading... -
+
P2.01-14 - Phase 3 Trial of Sitravatinib Plus Nivolumab vs Docetaxel for Treatment of NSCLC After Platinum-Based Chemoimmunotherapy
10:15 - 10:15 | Presenter: Emmanuel Nidhiry | Author(s): Tarek Mekhail, Eddie Thara, Misako Nagasaka, Christopher Chen, Bala Ganesh Gopurala, Nicholas Campbell, Keith Eaton, Yaser Homsi, Ronald Yanagihara, Raju Vaddepally, Xiaohong Yan, Vanessa Tassell, saskia Neuteboom, Richard Chao, Robert Keresztes
- Abstract
Loading... -
+
P2.01-15 - Phase II Single Arm Study of CABozantinib in Non-Small Cell Lung Cancer Patients with MET Deregulation (CABinMET)
10:15 - 10:15 | Presenter: Manolo D'Arcangelo | Author(s): Davide Tassinari, Filippo De Marinis, Angelo Delmonte, Domenico Galetta, Fabiana Letizia Cecere, Sara Pilotto, francesca Zanelli, Laura Bonanno, Lorenza Landi, Federica D'Incà, Federico Cappuzzo
- Abstract
Loading... -
+
P2.01-16 - TACTICAL: A Phase I/II Trial to Assess the Safety and Efficacy of MSCTRAIL in Metastatic Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Alice Davies | Author(s): Elizabeth Sage, Krishna Kolluri, Rebecca Graham, Ben Weil, Rita Rego, Owen Bain, P. Stephen Patrick, Kim Champion, Alex Day, Bilyana Popova, Graham Wheeler, Dan Fullen, Tammy Kalbur, Martin David Forster, Mark Lowdell, Sam Janes
- Abstract
Loading... -
+
P2.01-17 - CANOPY-1: Phase 3 Study of Canakinumab/Placebo+Pembrolizumab+Platinum-Chemotherapy in Untreated Stage IIIB-IV NSCLC Pts
10:15 - 10:15 | Presenter: Enriqueta Felip | Author(s): Gilberto Castro, Alastair Greystoke, Benjamin J Solomon, Daniel SW Tan, Vanessa Q. Passos, Stephanie Deudon, Anne Laure Louveau, Bruce E Johnson
- Abstract
Loading... -
+
P2.01-18 - ORION: A Phase 2, Randomised, Multicentre, Double-Blind Study to Assess Efficacy and Safety of Durvalumab+Olaparib Versus Durvalumab Alone as Maintenance Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Teresa Improta | Author(s): Myung-Ju Ahn, Yufan Liu, Michelle Marcovitz, Kateyln Dipiazza, Mark Lanasa
- Abstract
Loading... -
+
P2.01-19 - Phase 2 Study of Telisotuzumab Vedotin (Teliso-V) in Previously Treated c-MET+ Non-Small Cell Lung Cancer: Trial in Progress
10:15 - 10:15 | Presenter: Christopher Ocampo | Author(s): Jun Wu, Jyotirmoy Dey, Zhaowen Sun, Monica Motwani, Anita Reddy, Apurvasena Parikh, J. Wilken Hay, Philip Komarnitsky, Bruce Bach
- Abstract
Loading... -
+
P2.01-20 - Anlotinib vs. Docetaxel in Advanced Non-Squamous NSCLC (EGFR Wild-Type) After Progression on Platinum-Based Chemotherapy: A Trial Protocol
10:15 - 10:15 | Presenter: Wenxiu Yao
- Abstract
Loading... -
+
P2.01-21 - Efficacy and Safety of Combing Anlotinib and Erlotinib as a First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Tianqing Chu | Author(s): Baohui Han, Chunlei Shi, Hua Zhong, Wei Zhang, Bo Zhang, Runbo Zhong, Xueyan Zhang
- Abstract
Loading... -
+
P2.01-22 - ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy
10:15 - 10:15 | Presenter: Helena A Yu | Author(s): Sarah B. Goldberg, Xiuning Le, Zofia Piotrowska, Paul Smith, Ilhem Mensi, Bistra Kirova, Juliann Chmielecki, Xiaocheng Li-Sucholeicki, Philip Szekeres, Gail Doughton, Gargi Patel, Philip J Jewsbury, Jonathan W. Riess
- Abstract
Loading... -
+
P2.01-23 - DUBLIN-3, a Phase (Ph) III Trial Comparing the Plinabulin (P)/Docetaxel(D) Combination with D Alone in Stage IIIb/IV NSCLC
10:15 - 10:15 | Presenter: Ramon W Mohanlal | Author(s): Yan Sun, Goetz H. Kloecker, Trevor Feinstein, Yuankai Shi, Baohui Han, Lyudmila Bazhenova, Lihua Du, Lan Huang
- Abstract
Loading... -
+
P2.01-24 - CANOPY-2: Phase 3 Study of Canakinumab Plus Docetaxel as Second/Third Line Therapy in Locally Advanced/Metastatic NSCLC
10:15 - 10:15 | Presenter: Luis Paz-Ares | Author(s): Yasushi Goto, Darren WT Lim, Vassiliki A Papadimitrakopoulou, Bijoyesh Mookerjee, Isabelle Malet, Zhu Zewen, Martin Reck
- Abstract
Loading... -
+
P2.01-25 - TOURIST: Thoracic Umbrella Radiotherapy Study in Stage IV NSCLC: A Phase III Randomized Trial in Development
10:15 - 10:15 | Presenter: David Woolf | Author(s): Caroline Lee, Riyaz Shah, Merina Ahmed, Ian Fraser, Lucinda Billingham, iain Phillips, Jonathan McAleese, Crispin Hiley, Amy Taylor, Lynn Calman, Barton Rachael, Matthew Hatton
- Abstract
Loading... -
+
P2.01-26 - EMPOWER-Lung 3: Phase 3 Study of Combinations of Cemiplimab and Chemotherapy in First-Line Treatment of Advanced NSCLC
10:15 - 10:15 | Presenter: Sue Lee | Author(s): Miranda Gogishvili, Niloufar Mobashery, Tamta Makharadze, Mark Navarro, Pamela Snodgrass, Huanyu Chen, Israel Lowy, Petra Rietschel
- Abstract
Loading... -
+
P2.01-27 - Apparent Diffusion Coefficient (ADC) Change on Repeated Diffusion-Weighted MRI During Chemotherapy for Stage IV Lung NSCLC
10:15 - 10:15 | Presenter: Oscar Grundberg | Author(s): Mikael Skorpil, Signe Swerkersson, Karl Kölbeck, Reza Karimi, Luigi De Petris
- Abstract
Loading... -
+
P2.01-28 - The Predictive Factor for Prolonged Air Leakage Over 48 Hours Using Log Data of Digital Drainage System
10:15 - 10:15 | Presenter: Hironobu Hoshino | Author(s): Keiju Aokage, Shinya Katsumata, Shoko Nakasone, Tomohiro Miyoshi, Kenta Tane, Masahiro Tsuboi
- Abstract
Loading... -
+
P2.01-29 - The Correlation Between K-Ras Mutant Subsets with TP53 Mutation and PD-L1 in Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Nagla Abdel Karim | Author(s): Chisom Onuoha, Ihab Eldesouki, Imran Ahmad, Hirva Mamdani, Alexander Spira, abdul rafeh Naqash
- Abstract
Loading... -
+
P2.01-30 - Hepatitis B Infection or Aminotransferase Increase Associate with Poor Outcome of Anti-PD-1 Monotherapy in Patients with Advanced NSCLC
10:15 - 10:15 | Presenter: Yiwei Liu | Author(s): Shiqi Mao, Fei Zhou, Anwen Xiong, Bin Chen, Jia Yu, fengying Wu, Yayi He, Guanghui Gao, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P2.01-31 - Preliminary Results of Second Generation ALK Inhibitor PLB1003: A Phase La Study
10:15 - 10:15 | Presenter: Baohui Han | Author(s): Tianqing Chu, jialin Qian, Bo Yan, Yanwei Zhang, Qing Chang
- Abstract
Loading... -
+
P2.01-32 - The Impact of Segmentectomy Versus Lobectomy on Pulmonary Function of Patients with Non-Small Cell Lung Cancer: A Meta-Analysis
10:15 - 10:15 | Presenter: Guanping Qiu | Author(s): Yaokai Wen
- Abstract
Loading... -
+
P2.01-33 - Survival Benefit of Depleting High Serum EGF Concentration in Advanced NSCLC Patients as Switch Maintenance Therapy
10:15 - 10:15 | Presenter: Orestes Santos Morales | Author(s): Elia Neninger, Ramón Ortiz Carrodeguas, Patricia Lorenzo Luaces, Pedro Camilo Rodríguez, Maurenis Hernandez, Carmen Viada González, Tania Crombet
- Abstract
Loading... -
+
P2.01-34 - Endostar Combined with Whole Brain Radiotherapy in Patients with NSCLC Brain Metastases
10:15 - 10:15 | Presenter: Xiaorong Dong | Author(s): Lingjuan Chen, Chunhua Wei, Ruiguang Zhang, Gang Wu
- Abstract
Loading... -
+
P2.01-35 - Acquired MET-Aberrance Is a Mechanism of Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer
10:15 - 10:15 | Presenter: Qiu-Mei Deng | Author(s): Jin Kang, Han-Min Wang, Jin-Ji Yang, Hong-hong Yan, Zhen Wang
- Abstract
Loading... -
+
P2.01-36 - A Pilot Study on Cerebrospinal Fluid Cell-free DNA Sequencing in Leptomeningeal Metastasis from Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Xi Wu | Author(s): Jun-Ling Li
- Abstract
Loading... -
+
P2.01-37 - Lower Risk of Hypercoagulability in Non-Small Cell Lung Cancer Patients with EGFR Mutations
10:15 - 10:15 | Presenter: Shuta Ohara | Author(s): Kenichi Suda, Toshiki Takemoto, Masaya Nishino, Masato Chiba, Toshio Fujino, Akira Hamada, Takamasa Koga, Junichi Soh, Tetsuya Misudomi
- Abstract
Loading... -
+
P2.01-38 - Gene Expression Profiling of CNS Metastases in Non-Small Cell Lung Cancer - Matched Analyses with Primary Tumors
10:15 - 10:15 | Presenter: Georgios Tsakonas | Author(s): Per Hydbring, Simon Ekman
- Abstract
Loading... -
+
P2.01-39 - Serial Plasma ctDNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in T790M+ NSCLC
10:15 - 10:15 | Presenter: Bin-Chi Liao | Author(s): Wei-Hsun Hsu, Jih-Hsiang Lee, Ching-Yao Yang, Tzu-Hsiu Tsai, Wei-Yu Liao, Chao-Chi Ho, Chia-Chi Lin, Jin-Yuan Shih, Chong-Jen Yu, James Chih-Hsin Yang
- Abstract
Loading... -
+
P2.01-40 - Normalization of Carcinoembryonic Antigen Levels Is Associated with Survival Improvement in Patients with Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Roberto Iván Sánchez-Reyes | Author(s): Edgar Varela-Santoyo, Ariana Pereira-García, Feliciano Barrón, Andrés Felipe Cardona, Luis Cabrera-Miranda, Edgar Vergara, Luis Corrales, Claudio Martin, Oscar Gerardo Arrieta
- Abstract
Loading... -
+
P2.01-41 - EGFR Mutation Positive Non-Small Cell Lung Cancer: Management Approach and Survival Outcomes from the Hospital of Leon
10:15 - 10:15 | Presenter: Irene Pilar Delgado Sillero | Author(s): Mariana Lopez Flores, Luis Felipe Sánchez-Cousido, nerea Lopetegui Lia, Mariam Rojas Piedra, Nieves Alonso, cristina Diez Tascon, Soledad Medina, Manuela Pedraza, Ana López González, Beatriz Nieto Mangudo, Ángel Rodriguez, Luis De Sande, Carmen Castañón, Andrés García-Palomo, Pilar Diz
- Abstract
Loading... -
+
P2.01-42 - ALK-Rearrangement May Promote VTE by Increasing the Expression of TF in Advanced Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Sen Yang | Author(s): Qiming Wang
- Abstract
Loading... -
+
P2.01-43 - Pre-Therapeutic Markers and Scores Predict Response and Survival in Stage IV Lung Cancer Patients Independent of Histology
10:15 - 10:15 | Presenter: Diego Kauffmann-Guerrero | Author(s): Philipp Habisch, Jeremias Götschke, Zulfiya Syunyaeva, Pontus Mertsch, Amanda Tufman
- Abstract
Loading... -
+
P2.01-44 - Promoter Polymorphisms of TOP2A and ERCC1 Genes as Predictive Factors for Chemotherapy in Non-Small Cell Lung Cancer Patients
10:15 - 10:15 | Presenter: Justyna Błach | Author(s): Anna Grenda, Paweł Krawczyk, Marcin Nicoś, Michał Szczyrek, Barbara Kuźnar-Kamińska, Monika Jakimiec, Halina Batura-Gabryel, Marek Sawicki, Janusz Milanowski
- Abstract
Loading... -
+
P2.01-45 - Clinico-Molecular Characteristics and Prognostic Outcomes of TP53 Mutated Patients with Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Zizheng Song | Author(s): Huanqing Cheng, Ling Hu, Qiang Han, Xiaolei Wang, Yue Huo, Ting Jiao, Guanying Ren, Kunjie Wang, Baoyu Yin, Youchao Jia, Jin Song, Huina Wang, Feng Lou, Shanbo Cao, Aimin Zang
- Abstract
Loading... -
+
P2.01-46 - The Efficacy and Safety of 2nd-Line Nivolumab for Non-Small Cell Lung Cancer in Real-World Practice with Emphasis on Hyperprogession
10:15 - 10:15 | Presenter: Jae Cheol Lee | Author(s): Chang-Min Choi, Wonjun Ji, Soo Han Kim
- Abstract
Loading... -
+
P2.01-47 - Ipsilateral Lung Dose Constraints Predict Radiation Pneumonitis Better Than Conventional Ones in NSCLC Patients Treated with RCT
10:15 - 10:15 | Presenter: Deniz Yalman | Author(s): Esra Korkmaz Korkmaz Kıraklı, Sevilay Erdem, Eser Erim
- Abstract
Loading... -
+
P2.01-48 - Enhanced Expression of miR-204 Reduces Cisplatin Resistance in NSCLC
10:15 - 10:15 | Presenter: Zhuo Cao
- Abstract
Loading... -
+
P2.01-49 - Targeting STAT3-Positive Reactive Astrocytes with Silibinin in the Therapeutic Landscape of Non-Small-Cell Lung Cancer with Brain Metastases
10:15 - 10:15 | Presenter: Joaquim Bosch-Barrera | Author(s): Neibla Priego, Montserrat Puigdemont, Elia Sais, Nuria Quer, Angel Izquierdo, Alejandro Hernandez, Elisabet Cuyàs, Anna Carbó, Eduard Teixidor, Sara Verdura, Deysi Garcia, Alvar Roselló, Victoria Garriga, Salvador Pedraza, Joan Brunet, Alfonso Calvo, Javier Menéndez, Manuel Valiente
- Abstract
Loading... -
+
P2.01-50 - CD 146 a Potential Therapeutic Target for Lung Cancer
10:15 - 10:15 | Presenter: Ayobami Matthew Olajuyin | Author(s): Adefunke Kafayat Olajuyin, Zhao Xingru, Qin Fagyuan, Wang Zhiti, Xing Yasi, Xiaoju Zhang, Zhia Yaping
- Abstract
Loading... -
+
P2.01-51 - Next-Generation Sequencing for Effective Detection of Various EGFR Exon 20 Insertions (E20ins) in Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Inhwan Hwang | Author(s): Sang-we Kim, Sung-Min Chun, Shinkyo Yoon, Dae Ho Lee
- Abstract
Loading... -
+
P2.01-52 - Clinical Characteristics and Outcomes in NSCLC Patients Associated with Very High PD-L1 Expression
10:15 - 10:15 | Presenter: Erin Marie McLoughlin | Author(s): Laura Hanson, Margaret Moore, Bethany Horton, Ryan D Gentzler, Richard D Hall
- Abstract
Loading... -
+
P2.01-53 - Surgical Resection of Primary Tumor Improve the Prognosis of Lung Cancer Patients with Bone Metastasis
10:15 - 10:15 | Presenter: Dan Tian | Author(s): Xuanye Zhang, Xiaosong Ben, Guibin Qiao
- Abstract
Loading... -
+
P2.01-54 - Real-World PD-L1 Testing Patterns for Patients with Advanced Non-Small Cell Lung Cancer in Greece
10:15 - 10:15 | Presenter: Konstantinos Syrigos | Author(s): Violeta Grammatikou, Eleni Kokkotou, Andriani Charpidou, Aggeliki Papaspiliou, Lamprini Stournara, FLAVIA Ejzykowicz
- Abstract
Loading... -
+
P2.01-55 - Immunotherapy First or After Nintedanib?: A Spanish Experience
10:15 - 10:15 | Presenter: Laura Gutiérrez Sainz | Author(s): Patricia Cruz, Carlos Aguado, Mónica Antoñanzas, Xavier Mielgo, Luis Cabezón, Luis Enrique Chara, Isabela Gomez-Barreda, Elia Martinez Moreno, Yolanda Lage Alfranca, Alejandro Velastegui, Miguel Sotelo, Ana Garcia Rueda, María Eugenia Olmedo, Sergio Martínez Recio, Javier De Castro Carpeno
- Abstract
Loading... -
+
P2.01-56 - Copy Number Gains (CNGs) of Clinically Relevant Genes in Advanced NSCLC Patients
10:15 - 10:15 | Presenter: Clara Mayo De Las Casas | Author(s): Mónica Garzón, Núria Jordana, Beatriz García, Ruth Román, Jordi Bertrán-Alamillo, Sonia Rodriguez, Erika Aldeguer, Silvia Garcia Román, Santiago Viteri, Andrés Aguilar Hernandez, Maria Gonzalez-Cao, Manuel Fernández-Bruno, Niki Karachaliou, Alejandro Martinez-Bueno, Irene Moya, Miguel Angel Molina-Vila, Rafael Rosell
- Abstract
Loading... -
+
P2.01-57 - New Prognostic Markers in Patients with Lung Cancer Treated with Immunoterapy: NLR and PLR
10:15 - 10:15 | Presenter: Seyda Gunduz | Author(s): Mustafa Ozdogan, Onder Kırca, Muharrem Okan Çakır, Aysegül Kargı, Mukremin Uysal, Vildan Kaya, Necdet öz, Akın Yıldız
- Abstract
Loading... -
+
P2.01-58 - Detection of Kras Mutation from Urine of Indonesian Lung Cancer Patients
10:15 - 10:15 | Presenter: Asep Muhamad Ridwanuloh | Author(s): Farizul Fadiyah, Fadillah Putri Patria, Refniwita Yasril, Achmad Hudoyo, Jamal Zaini, Sita Andarini, Najmiatul Masykura, Ahmad Rusdan Utomo
- Abstract
Loading... -
+
P2.01-59 - PD-L1 Very High Expression Associated with Clinical Outcome of Pembrolizumab Monotherapy of Advanced NSCLC with PD-L1 TPS of 50% or Greater
10:15 - 10:15 | Presenter: Hidetoshi Itani | Author(s): Akina Nigi, Kesuke Iwamoto, Yuhei Ito, Motoaki Tanigawa, Shigeto Kondo
- Abstract
Loading... -
+
P2.01-60 - Analysis of Prognostic Factors According to Performance Status in Non-Small Cell Lung Cancer Patients Treated with Nivolumab
10:15 - 10:15 | Presenter: Yuichi Adachi | Author(s): Akihiro Tamiya, Yoshihiko Taniguchi, Takatoshi Enomoto, Kouji Azuma, Shunichi Kouno, Nobuhiko Saijo, Kyouichi Okishio, Shinji Atagi
- Abstract
Loading... -
+
P2.01-61 - Multiple Primary Carcinomas (MPC) in Patients with Non Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Michael M. Vaslamatzis | Author(s): Nektarios Alevizopoulos, Theodoros Tegos, Michael George Pavlakis, Konstantina Karagiorgou, Charalambos Zoumblios, Katerina Gioti, Vasiliki Nikolaidou, Helen Kyriazidou, Evangelos Balis, Kalliopi Athanasiadou
- Abstract
Loading... -
+
P2.01-62 - Circulating Tumor DNA Assay and Survival in Patients with Metastatic, Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Emma Green | Author(s): Jennifer L Ersek, Madeline Hosking, James Symanowski, Qing Zhang, Edward S Kim
- Abstract
Loading... -
+
P2.01-63 - Radiosurgery Followed by Tumor Treating Fields (TTFields) for Brain Metastases (1-10) from NSCLC in the Phase 3 METIS Trial
10:15 - 10:15 | Presenter: Uri Weinberg | Author(s): Minesh P. Mehta, Vinai Gondi, Manmeet Ahluwalia, Paul D. Brown
- Abstract
Loading... -
+
P2.01-64 - Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer
10:15 - 10:15 | Presenter: Ahmet Bilici | Author(s): Omer Fatih Olmez, Pinar Gursoy, Erdem Çubukçu, Ozcan Yildiz, Abdullah Sakin, Taner Korkmaz, Ibrahim Cil, Burcu Cakar, Serkan Menekse, Tarik Demir, Ozgur Acikgoz, Jamshid Hamdard
- Abstract
Loading... -
+
P2.01-65 - Temporal Changes of Radiation-Induced Lung Injury Following Proton Therapy for Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Leonid Roshkovan | Author(s): Alicia Lozano, Alexandra Hanlon, Varsha Jain, Keith Cengel, Charles B. Simone, Li, Abigail Berman, Steven Feigenberg, Sharyn I Katz
- Abstract
Loading... -
+
P2.01-66 - Genomic Landscapes of DNA Copy Number Alterations in Primary Lung Cancers and Matched Brain Metastases
10:15 - 10:15 | Presenter: Marcin Nicoś | Author(s): Silvano Garnerone, Luuk Harbers, Anna Kowalczyk, Aleksandra Bożyk, Rafal Peksa, Bozena Jarosz, Adrian Perdyan, Marek Sawicki, Renata Duchnowska, Justyna Szumilo, Wojciech Biernat, Tomasz Trojanowski, Janusz Milanowski, Paweł Krawczyk, Jacek Jassem, Nicola Crosetto
- Abstract
Loading... -
+
P2.01-67 - Are KRAS Mutations Predictive of Response to Immunotherapy in Non Small-Cell Lung Cancer? A Single Center Experience
10:15 - 10:15 | Presenter: Alex Friedlaender | Author(s): Javier Torralvo, Pierre-Yves Dietrich, Alfredo Addeo
- Abstract
Loading... -
+
P2.01-68 - High NLR Is Poor Predictive Biomarker for NSCLC Treated with PD-1 Inhibitor in Real World Practice
10:15 - 10:15 | Presenter: Sung Shim Cho | Author(s): Sung Kyoung Kim, Hyung Soon Park, Ho Jung An, Kyu Do Cho, Deog Gon Cho, Young Ha Park, Jinyoung Yoo, Sung Whan Kim, Jeong Min Ko, Yun Sun Hwang, Gyu Rim Heo, Chi Hong Kim, Byoung Yong Shim, Eun Jung Park
- Abstract
Loading... -
+
P2.01-69 - NSCLC Mutation Frequency in the Central American and Caribbean Region
10:15 - 10:15 | Presenter: Luis Corrales | Author(s): Erick Alexander Arauz-Romero, Mario Lanza, Ludwig Bacon, Luis Homero-Matos, Carmen Vargas-Málaga
- Abstract
Loading... -
+
P2.01-70 - Therapy with Osimertinib in Patients with T790M Mutation: Experience of a Portuguese Oncology Center
10:15 - 10:15 | Presenter: Isabel Sofia Azevedo Pereira | Author(s): Iolanda Vieira, Ana Rodrigues, Inés Pousa, Júlio Oliveira, Maria Cassiano, Cristina Oliveira, Alina Rosinha, Isabel Azevedo, Marta Soares
- Abstract
Loading... -
+
P2.01-71 - Comprehensive Analysis of EGFR T790M-Mutant Abundance of Different Technologies and Its Effect on Efficacy of Osimertinib in Advanced NSCLC
10:15 - 10:15 | Presenter: Yun Fan | Author(s): Xiaoqing Yu
- Abstract
Loading... -
+
P2.01-72 - Safety of Palliative Radiotherapy and Immune Checkpoint Inhibitors in Patients with Metastatic Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Michael Chandra Tjong | Author(s): Malavan Ragulojan, Ian Poon, Susanna Y Cheng, Mark Doherty, Yee Ung, Patrick Cheung, Parneet K Cheema
- Abstract
Loading... -
+
P2.01-73 - Outcome Disparities in American Indian/Alaskan Natives with Advanced Stage Lung Cancer
10:15 - 10:15 | Presenter: Jessica Hellyer | Author(s): Kristen Cunanan, Heather A Wakelee, Summer S Han
- Abstract
Loading... -
+
P2.01-74 - Clinical-Pathological Features and Outcome of Patients with Oral Metastases from Lung Cancer: A Multicenter Retrospective Study
10:15 - 10:15 | Presenter: Marco Tagliamento | Author(s): Daniele Pignataro, Paolo Bironzo, Marcello Tiseo, Anna Maria Militello, Giuseppe Banna, Domenico Galetta, Francesco Pesola, Gabriella Del Bene, Melania Lupatelli, Matteo Val, Emanuela Olmetto, Enrica Capelletto, Monica Pentenero, Silvia Novello
- Abstract
Loading... -
+
P2.01-75 - Temporal Trends in Treatment Patterns for Advanced/Metastatic Non-Small Cell Lung Cancer (aNSCLC) in Routine Clinical Practice
10:15 - 10:15 | Presenter: Victoria J Stefaniak | Author(s): Katherine B Winfree, Zhanglin Lin Cui, Cliff Molife
- Abstract
Loading... -
+
P2.01-76 - Bone Metastasis and Pleural Dissemination as a Potential Marker for Predicting of T790M Mutation in Advanced Non-Small Cell Lung Cancer Patients
10:15 - 10:15 | Presenter: Fumiyoshi Ohyanagi | Author(s): Yoshiko Mizushina, Motoko Nomura, Fumiaki Kudo, Jun Shiihara, Hiromitsu Ohta, Shinichiro Koyama
- Abstract
Loading... -
+
P2.01-77 - PET CT Radiogenomic Depiction with EGFR and ALK Molecular Alterations in Lung Cancer Among Indian Population
10:15 - 10:15 | Presenter: Venkata Pradeep Babu Koyyala | Author(s): Ankush Jajodia, Rupal Tripathi, Arvind Chaturvedi, Sunil Pasricha, Sumit Goyal, Ullas Batra, Anurag Mehta, Helmut Prosch
- Abstract
Loading... -
+
P2.01-78 - A Meta‑Analysis and Bioinformatics Exploration of the Prognostic Value of TP53 Co-Mutations in EGFR Mutated NSCLC
10:15 - 10:15 | Presenter: Richeng Jiang | Author(s): Fan Wang, shouying Li, Xinyue Wang, Liuchun Wang, Dingzhi Huang
- Abstract
Loading... -
+
P2.01-79 - Afatinib in EGFR Mutation-Positive (EGFRm+) NSCLC Harbouring Uncommon Mutations: Experience in ‘Real-World’ Clinical Practice
10:15 - 10:15 | Presenter: Yi-Long Wu | Author(s): Wolfgang Brückl, Eckart Laack, Christopher Hoffmann, Caicun Zhou
- Abstract
Loading... -
+
P2.01-80 - Clinical Outcomes in Advanced EGFR-Mutant NSCLC Patients Treated with First-Generation EGFR TKIs Followed by Subsequent Osimertinib
10:15 - 10:15 | Presenter: Yi-Hui Yao | Author(s): Jiang-Tao Cheng, Jin Kang, Xiang-Meng Li, Hua-Jun Chen, Qing Zhou, Chongrui Xu, Xu-Chao Zhang, Jian Su, Hong-Hong Yan, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P2.01-81 - Predictive Factors of Survival in Patients Treated with Nintedanib: A Multicenter Retrospective Spanish Study
10:15 - 10:15 | Presenter: Laura Gutiérrez Sainz | Author(s): Patricia Cruz, Mónica Antoñanzas, Carlos Aguado, Xavier Mielgo, Luis Cabezón, Luis Enrique Chara, Elia Martinez Moreno, Yolanda Lage Alfranca, Alejandro Velastegui, Miguel Sotelo, Ana Garcia Rueda, María Eugenia Olmedo, Sergio Martínez Recio, Javier De Castro Carpeno
- Abstract
Loading... -
+
P2.01-82 - Lung Cancer in Lung Transplant Recipients
10:15 - 10:15 | Presenter: Shinji Otani | Author(s): Toshio Shiotani, Ken Suzawa, Kentaroh Miyoshi, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Masaomi Yamane, Takahiro Oto, Shinichi Toyooka
- Abstract
Loading... -
+
P2.01-83 - Role of Exosomal MicroRNAs (miRNAs) as Predictors of Response to Treatment and Prognosis in Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Mohammad Razaq | Author(s): Vipul Pareek, Akhil Srivastava, Rajagopal Ramesh
- Abstract
Loading... -
+
P2.01-84 - Serumal SERPINE2 as a Potential Biomarker for Radioresistance in NSCLC
10:15 - 10:15 | Presenter: Jingjing Zhang | Author(s): Qiong Wu, Lucheng Zhu, YANYAN Zhao, Shujun Xie, Yuqing Wang, Shirong Zhang, Shenglin Ma
- Abstract
Loading... -
+
P2.01-85 - Schwann Cells Are Overexpressed and Inversely Correlated with Survival of Non-Small Cell Lung Cancer Patients
10:15 - 10:15 | Presenter: Yan Zhou | Author(s): Hua Zhong, Baohui Han
- Abstract
Loading... -
+
P2.01-86 - Highly Immunogenic Neoantigens Enhance Tumor Response to Immune Checkpoint Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Di Wu | Author(s): Jinsong Yang, Yiying Liu, Xiaohua Hong, Kai Zhang, Feifei Gu, Yuting Liu, Zhikun Zhao, Yue Hu, Li Liu
- Abstract
Loading... -
+
P2.01-87 - β-Adrenergic Antagonists Sensitizes Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Sherry Yan | Author(s): Kunal Chaudhary, Balazs Halmos, Tony Wang, Tom Hei, Simon Cheng
- Abstract
Loading... -
+
P2.01-88 - Molecular Alterations in Cerebrospinal Fluid Predict Clinical Outcomes of Central Nervous System Metastases in Lung Cancer
10:15 - 10:15 | Presenter: Meimei Zheng | Author(s): Yangsi Li, Benyuan Jiang, Haiyan Tu, Junyi Ye, Jin-Ji Yang, Xu-Chao Zhang, Shannon Chuai, Hao Sun, Qing Zhou, Wen-Zhao Zhong, Yi-Long Wu
- Abstract
Loading... -
+
P2.01-89 - Feasibility of Individualized Multidisciplinary Treatment for Locally Advanced Non-Small Cell Lung Cancer Based on the Treatment Planning
10:15 - 10:15 | Presenter: Yu Liu, Yaping Xu | Author(s): Shuangyan Yang, Ying Ye, Yaoyao Zhu, Qinghua Xu
- Abstract
Loading... -
+
P2.01-90 - Dosimetry Prediction of Locally Advanced Non-Small Cell Lung Cancer Based on the Tumor Location and the Volume Ratio of Tumor to Lung
10:15 - 10:15 | Presenter: Shuangyan Yang | Author(s): Ying Ye, Yaoyao Zhu, Yaping Xu
- Abstract
Loading... -
+
P2.01-91 - Exosomal Analysis of ALK Rearrangements by Spin Column with Porous Glass Filter
10:15 - 10:15 | Presenter: Takahiro Hatta | Author(s): Tetsunari Hase, Naoya Ozawa, Naoyuki Yogo, Hiroshi Yukawa, Hiromasa Tanaka, Daisuke Onoshima, Mitsuo Sato, Masaru Hori, Yoshinobu Baba, Yoshinori Hasegawa
- Abstract
Loading... -
+
P2.01-92 - Cimavax-EGF in Combination with First-Line Chemotherapy in III Stage NSCLC
10:15 - 10:15 | Presenter: Elia Neninger | Author(s): Haslen Caceres, Kirenia Camacho, Maurenis Hernandez, Eduardo Santiesteban, Concepción Del Castillo, Yanet Menendez, Barbara Gonzalez
- Abstract
Loading... -
+
P2.01-93 - Detection of Giant Cancer-Associated Macrophage-Like Cells After Concurrent Chemoimmunoradiation Is Associated with Poor Survival in NSCLC
10:15 - 10:15 | Presenter: Alexander Augustyn | Author(s): Daniel Adams, Jianzhong He, Yawei Qiao, Ting Xu, Zhongxing Liao, Ashvathi Raghavakaimal, Kirby Gardner, Cha-Mei Tang, John Victor Heymach, Anne Tsao, Steven H Lin
- Abstract
Loading... -
+
P2.01-94 - Advanced Age and High Modified Glasgow Prognostic Score Are Associated with Increased Complications After Pneumonectomy
10:15 - 10:15 | Presenter: Mohamed Zaatar | Author(s): Theresa Stork, Lasse Fangmann, Anna Martens, Stephane Collaud, Khaled Mardanzai, Till Plönes, Daniel Valdivia, Martin Schuler, Martin Stuschke, Kaid Darwiche, Balazs Hegedus, Clemens Aigner
- Abstract
Loading... -
+
P2.01-95 - Updated Data of KRSG 1302 Study: Nedaplatin and Nab-Paclitaxel for Patients with Previously Untreated Advanced Squamous Cell Lung Cancer
10:15 - 10:15 | Presenter: Fumiyoshi Ohyanagi | Author(s): Yoshiaki Nagai, Takashi Kasai, Nobuyuki Koyama, Kunihiko Kobayashi, EISHIN Hoshi, Mitsuo Nakayama, Kiyoshi Mori
- Abstract
Loading... -
+
P2.01-96 - Response to Anti-HER2 Afatinib in a Case of Invasive Pulmonary Mucinous Adenocarcinoma with a SLC3A2-NRG1 Fusion
10:15 - 10:15 | Presenter: Fanny Magne | Author(s): Veronique Haddad, Luc Odier, Michael Duruisseaux, Sonia Blandin, Christine Dussopt, Lionel Falchero, Dominique Arpin
- Abstract
Loading... -
+
P2.01-97 - Angiotensin-Converting Enzyme Inhibitor Is Associated with Decreased Survival in NSCLC Patients Treated with PD-1 Checkpoint Blockers
10:15 - 10:15 | Presenter: Corentin Richard | Author(s): Soleine Medjbar, Jean-David Fumet, Julie Malo, Arielle Elkrief, Bertrand Routy, Romain Boidot, Caroline Truntzer, Francois Ghiringhelli
- Abstract
Loading... -
+
P2.01-98 - Neutrophil-Platelet Score (NPS), a Predictive Systemic Inflammation Score for Pembrolizumab in First Line of Advanced NSCLC Patients
10:15 - 10:15 | Presenter: Xabier Mielgo Rubio | Author(s): Patricia Cruz, María Sereno, Luis Enrique Chara, Luis Cabezon-Gutierrez, Alejandro Velastegui, Ana López, Rafael Lopez Castro, Miguel Sotelo, Judit Rubio, Juan Antonio Núñez, Elia Pérez Fernández, Clara Olier, Javier De Castro Carpeno, Mónica Antoñanzas, Sandra Falagan, Irene Nalda Ariza, Sara Custodio, Patricia Dhimes, Carlos Aguado
- Abstract
Loading... -
+
P2.01-99 - A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Final Analysis
10:15 - 10:15 | Presenter: Yi-Long Wu | Author(s): Haiyan Tu, Jifeng Feng, Meiqi Shi, Jun Zhao, Yuyan Wang, Jianhua Chang, Jialei Wang, Ying Cheng, Jing Zhu, Eng-Huat Tan, Yiping Zhang, Victor Lee, Cheng-Ta Yang, Wu-Chou Su, David Chi-Leung Lam, BJ Srinivasa, Senthil Rajappa, Ching-Liang Ho, Kwok Chi Lam, Yi Hu, Shailesh Arjun Bondarde, Xiaoqing Liu, Kaimin Pang, Yahui Tian, Agnieszka Cseh, Dennis Chin-Lun Huang, Caicun Zhou
- Abstract
Loading...
-
+
P2.02 - Advocacy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advocacy
-
+
P2.02-01 - ALKFusion and the Unmet Need of Patient-Centric Research
10:15 - 10:15 | Presenter: Laura M Greco | Author(s): Shelly Engfer-Triebenach, colleen Conner Ziegler
- Abstract
Loading...
-
+
P2.03 - Biology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P2.03-01 - MMP1 Secreted by Cancer Cells Induces a Pro-Tumorigenic Senescent Phenotype in Fibroblasts in Large Cell Carcinoma of the Lung
10:15 - 10:15 | Presenter: Marta Gabasa | Author(s): Rafael Yamashita Ikemori, Evette Radisky, Noemi Reguart, Derek Radisky, Jordi Alcaraz
- Abstract
Loading... -
+
P2.03-02 - A Single Sample Predictor of Transcriptional Lung Adenocarcinoma Subtypes: Predicting Biology and Prognosis
10:15 - 10:15 | Presenter: Anna F Karlsson | Author(s): Helena Cirenajwis, Maria Planck, Johan Staaf
- Abstract
Loading... -
+
P2.03-03 - Landscape of Gene Fusions in Lung Adenocarcinoma Patients with Minimal Cigarette Exposure Identified on Malignant Pleural Effusions
10:15 - 10:15 | Presenter: Maria Saigi | Author(s): Eva Pros, Juan José Alburquerque Béjar, Isabel Català, Sara Verdura, Ramon Palmero Sánchez, Maria Jove, Ernest Nadal, Montse Sanchez-Cespedes
- Abstract
Loading... -
+
P2.03-04 - The Prognostic Value of Serological Tumor Markers in Lung Cancer – Analysis of 13,373 Cases
10:15 - 10:15 | Presenter: Thomas Muley | Author(s): Karsten Senghas, Sonja Kobinger, Michael Meister, Marc Andre Schneider, Esther Herpel, Michael Thomas, Hauke Winter, Claus-Peter Heussel, Felix Herth
- Abstract
Loading... -
+
P2.03-05 - PHLPP1 Expression Through AKT and ERK Dual Signaling Pathways May Slow Down the Resistance to TKI in EGFR-Mutated Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Wei Wang | Author(s): Dongqing Lv, Yinnan Meng, Minhua Ye, Suna Zhou, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
P2.03-06 - Detection of ctDNA and Correlation with Tumor Mutation Testing in Early Stage NSCLC
10:15 - 10:15 | Presenter: Anastasios Dimou | Author(s): Tejas Patil, Alyssa Jeffers, Amy Guimaraes-Young, Kurtis D. Davies, Tracy Nance, Yupeng He, Ariel Jaimovich, Victoria M Raymond, AmirAli Talasaz, Erin Schenk, Jose Pacheco, Dara Aisner, Daniel Merrick, Christopher Scott, JOHN D Mitchell, Michael Weyant, Robert A. Meguid, W. Thomas Purcell, Paul A Bunn, Jr, D. Ross Camidge, Terry L Ng, Caroline McCoach, Robert C. Doebele
- Abstract
Loading... -
+
P2.03-07 - Frequency of Driver Genes (EGFR, KRAS, BRAF, ALK, RET and ROS1) Alterations in Brazilian Patients with Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Letícia Ferro Leal | Author(s): Lazaro Antonio Campanha Novaes, Rodrigo de Oliveira Cavagna, Flávia Escremim De Paula, Pedro De Marchi, Maicon Fernando Zanon Da Silva, Adriane Feijó Evangelista, Luciane Sussuchi Da Silva, Eduardo Caetano Albino Da Silva, Rui Manuel Reis
- Abstract
Loading... -
+
P2.03-08 - Analysis of Immunosuppressive Factors Produced by CSCs Revealed Galectin-3 as Immune Modulator with Prognostic Value in NSCLC Adenocarcinoma
10:15 - 10:15 | Presenter: Alejandro Herreros-Pomares | Author(s): Susana Torres, FEIYU Zhang, Silvia Calabuig-Fariñas, Rafael Sirera, Marais Mosqueda, Eva Escorihuela, Álvaro González, Ning Dong, Sandra Gallach, Javier Garde, Ricardo Guijarro, Eloisa Jantus-Lewintre, Carlos Camps
- Abstract
Loading... -
+
P2.03-09 - Arf6-Related Invasive Pathway Deteriorated Patients’ Prognosis in Mutant EGFR Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Toshi Menju | Author(s): Misa Noguchi, Shigeyuki Tamari, Hiroyuki Ishikawa, Ryo Miyata, Shigeto Nishikawa, Koji Takahashi, Akihiko Yoshizawa, Hironori Haga, Hiroshi Date
- Abstract
Loading... -
+
P2.03-10 - Comprehensive Molecular Profiling and Comparison of Common and Rarer Subtypes of Lung Cancer
10:15 - 10:15 | Presenter: Clara Domingo-Sabugo | Author(s): Elizaberth Starren, Amit Mandal, Anca Mihaela Nastase, Long Hoang, Matthew Edwards, Deborah Morris-Rosendahl, Eric Lim, Andrew G Nicholson, Mark Lathrop, William O.C Cookson, Miriam F Moffatt
- Abstract
Loading... -
+
P2.03-11 - Impact of Ethnicity on Outcome in Never Smokers with EGFR and ALK Wildtype (EGFR/ALK-Wildtype) Lung Adenocarcinomas
10:15 - 10:15 | Presenter: Sebastiao N Martins-Filho | Author(s): Aline Fusco Fares, Vibha Raghavan, Erin L Stewart, deepti Ravi, Kirstin Perdrizet, jessica Weiss, Katrina Hueniken, Devalben Patel, Nhu-An Pham, Adrian G Sacher, Penelope A Bradbury, Natasha B Leighl, Frances Shepherd, Ming Sound Tsao, Geoffrey Liu
- Abstract
Loading... -
+
P2.03-12 - Epigenome-Wide Methylation Study from Blood Samples of Lung Cancer Patients and Controls
10:15 - 10:15 | Presenter: Yoonki Hong | Author(s): Hyung Gon Son, Ji Young Hong
- Abstract
Loading... -
+
P2.03-13 - Acquired Resistance to Afatinib in Non-Small Cell Lung Cancer with EGFR G719X Mutation
10:15 - 10:15 | Presenter: Taishi Harada | Author(s): Shun Futamura, Yu Inoue, Ryo Sawada, Takashi Okuda, Keizo Kagawa
- Abstract
Loading... -
+
P2.03-14 - Developing an Immunogenic Model of Non Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Sarah Anne Laing | Author(s): Sarah Edwards, Gerard Graham, Björn Kruspig, Seth Coffelt, Douglas Strathdee, Daniel Murphy
- Abstract
Loading... -
+
P2.03-15 - Validation of Tumor Organoids from Lung Adenocarcinoma as a Model of Primary Tumor Genotype
10:15 - 10:15 | Presenter: Jeffrey Allen Borgia | Author(s): Christopher W. Seder, Andrew T Arndt, Justin M Karush, Nicole Geissen, Conner Wakefield, Ankur Naqib, Michael J Liptay, Casey A Frankenberger
- Abstract
Loading... -
+
P2.03-16 - Agreement Between Different Methodologies for Non-Invasive p.T790M and EGFR Sensitizing Mutation Testing
10:15 - 10:15 | Presenter: Atocha Romero | Author(s): Eloisa Jantus, Miguel Angel Molina-Vila, Amelia Insa, Patricia Cruz, Ana Collazo, Javier Perez Altozano, Oscar Juan, Pilar Diz, Manuel Cobo, Berta Hernandez, Sergio Vazquez, Gretel Benitez, Maria Guirado, Margarita Majem, Reyes Bernabe, Ana Laura Ortega, Ana Blasco, Joaquim Bosch-Barrera, Jose M Jurado, JORGE Garcia, Santiago Viteri, Carlos Garcia Giron, Bartomeu Massuti, Ana Lopez Martin, Beatriz Garcia-Pelaez, Francisco Aparisi, Estela Sánchez Romero, Alejandro Rodríguez Festa, Silvia Calabuig-Fariñas, Rafael Rosell, Carlos Camps, Mariano Provencio
- Abstract
Loading... -
+
P2.03-17 - Optimization of an Ex-Vivo Preclinical Model for Drug Testing
10:15 - 10:15 | Presenter: Elba Marin | Author(s): Paula Duch, Marta Gabasa, Elisabet Urrea, Rafael Yamashita Ikemori, Natalia Isabel Díaz-Valdivia, Cristina Teixido, Noemi Reguart, Jordi Alcaraz
- Abstract
Loading... -
+
P2.03-18 - Pathogenic Germline Rare Variants and Risk of Lung Cancer
10:15 - 10:15 | Presenter: Yanhong Liu | Author(s): James McKay, Xiangjun Xiao, John Kirkpatrick Field, Michael Davies, Paul Brennan, Geoffrey Liu, Rayjean J. Hung On Behalf Of The International Lung Cancer Consortium, David C. Christiani, Christopher Ian Amos
- Abstract
Loading... -
+
P2.03-19 - Co-Targeting PIM Kinase to Overcome MET Amplified Resistance to EGFR TKIs in NSCLC
10:15 - 10:15 | Presenter: Kathy Ann Gately | Author(s): Anne Tranberg Madsen, Gillian Moore, Nathalie Simon, Amy Mahon, Sinead Cuffe, Stephen Finn, Michael O'Neill, Boe Sorensen
- Abstract
Loading... -
+
P2.03-20 - Potent in Vitro Activity of Tarloxotinib for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance
10:15 - 10:15 | Presenter: Takamasa Koga | Author(s): Kenichi Suda, Masaya Nishino, Toshio Fujino, Shuta Ohara, Junichi Soh, Avanish Vellanki, Vijaya G Tirunagaru, Tetsuya Misudomi
- Abstract
Loading... -
+
P2.03-21 - MUC16 Germline Mutations May Associate with Inherited Lung Cancer
10:15 - 10:15 | Presenter: Tao Wang | Author(s): Rui Lin, Hong Liu, Shanshan Xiao, Ruifang Mao
- Abstract
Loading... -
+
P2.03-22 - Chromate Exposure Induces DNA Hypermethylation of the Mismatch Repair Gene MLH1 in Lung Cancer
10:15 - 10:15 | Presenter: Kazuya Kondo | Author(s): Mitsuhiro Tsuboi, Shiho Soejima, Naoya Kawakita, Hiroaki Toba, Yukikiyo Kawakami, Mitsuteru Yoshida, Hiromitsu Takizawa, Akira Tangoku
- Abstract
Loading... -
+
P2.03-23 - UHRF1 as a Potential Therapeutic Target for KRAS Mutated Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Daiki Goto | Author(s): Mari Kizuki, Natsuki Uwatoko, Kaho Kawai, Mayu Koike, Moeka Nakashima, Ayako Miyazawa, Ichidai Tanaka, Tetsunari Hase, Masahiro Morise, Yoshinori Hasegawa, john Minna, Mitsuo Sato
- Abstract
Loading... -
+
P2.03-24 - Concurrent Aberrations in G2/M-Phase Transcriptional Programs and Genomic Gatekeepers Highlight Lung Cancer Predisposition in COPD Patients
10:15 - 10:15 | Presenter: Erin A Marshall | Author(s): Emily A Vucic, Raymond T Ng, Stephen Lam, Wan Lam
- Abstract
Loading... -
+
P2.03-25 - Assessing the Impact of Clonal Hematopoiesis in Disease Monitoring Using Targeted Cell-Free DNA (cfDNA) Sequencing Technology
10:15 - 10:15 | Presenter: Stephanie Yaung | Author(s): Liu Xi, Corinna Woestmann, Christine Ju, Daniel M. Klass, Fergal Casey, Bernd Hinzmann, Claus-Peter Heussel, Michael Thomas, Felix Herth, Thomas Muley, Birgit Wehnl, John F. Palma, Xiaoju Max Ma
- Abstract
Loading... -
+
P2.03-26 - Elucidating Mechanisms of Resistance to Targeted Therapies in Mutant EGFR or KRAS Driven Lung Adenocarcinoma Harboring Dual Loss of p53 and RB1
10:15 - 10:15 | Presenter: Yusuke Inoue | Author(s): Romel Somwar, Marc Ladanyi, William Lockwood
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-28 - A 500-Gene Panel to Detect Tumor Mutation Burden of Tissue and Plasma Samples from Lung Cancer Patients
10:15 - 10:15 | Presenter: Shanshan Xiao | Author(s): Rui Lin, Ruifang Mao, Tao Wang
- Abstract
Loading... -
+
P2.03-29 - Circulating Levels of Ligands for Receptor Tyrosine Kinases May Contribute to an Immunosuppressive Tumor Microenvironment
10:15 - 10:15 | Presenter: Jeffrey Allen Borgia | Author(s): Gabriela C Lobato, Mary Jo Fidler, Jared D Fialkoff, Marta Batus, Philip Bonomi
- Abstract
Loading... -
+
P2.03-30 - Genetic Characteristics of Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis
10:15 - 10:15 | Presenter: Soo Jung Kim | Author(s): Sejoon Lee, Jin-Haeng Chung, Sukki Cho, Jae Ho Lee, Choon-Taek Lee
- Abstract
Loading... -
+
P2.03-31 - Chemokine Receptor CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
10:15 - 10:15 | Presenter: Jeffrey Becker | Author(s): Yandi Gao, Margaret Soucheray, Inés Pulido, Eiki Kikuchi, María L. Rodríguez, Rutu Gandhi, Aranzazu Lafuente-Sánchis, Miguel Aupi, Javier Alcacer Fernandez-Coronado, Paloma Martín, Antonio Cremades, José M. Galbis-Caravajal, Javier Alcacer, Camilla L. Christensen, Patricia Simms, Ashley Hess, Hajime Asahina, Michael P Kahle, Fátima Al-Shahrour, Jeffrey Allen Borgia, Agustin Lahoz, Amelia Insa, Oscar Juan, Pasi A Jänne, Kwok-Kin Wong, Julian Carretero, Takeshi Shimamura
- Abstract
Loading... -
+
P2.03-32 - Metastatic Lymph Nodes as High Immunogenicity Media for Perioperative Immunotherapy in Locally Advanced NSCLC
10:15 - 10:15 | Presenter: Chao Zhang | Author(s): Si-yang Liu, Jian Su, Xuan Gao, Lian-peng Chang, Yan-Fang Guan, Hai-yan Tu, Qing Zhou, Jin-ji Yang, Xue-ning Yang, Xu-chao Zhang, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading... -
+
P2.03-33 - ctDNA Levels Significantly Predicts Survival in NSCLC Patients with an EGFR Activating Mutation
10:15 - 10:15 | Presenter: Atocha Romero | Author(s): Estela Sánchez Herrero, Fabio Franco, Mylda Auglite, Roberto Serna Blasco, Miguel Barquín Del Romo, Alfredo Sanchez-Hernandez, Carlos Garcia Giron, Manuel Dómine, Eloisa Jantus, Carlos Camps, José Miguel Sánchez, Juana Oramas, Luis Enrique Chara, Ana Laura Ortega, M.Angeles Sala, Berta Hernandez, María Sereno, Joaquim Bosch-Barrera, Airam Padilla, Jose Balsalobre, REmedios Blanco, Javier De Castro Carpeno, Xabier Mielgo Rubio, Miguel Sotelo, Juan Coves, Virginia Calvo De Juan, Mariano Provencio
- Abstract
Loading... -
+
P2.03-34 - Fractalkine Attenuate Irradiation-Induced Brain Injury Through Promoting the M2 Polarization of Microglia
10:15 - 10:15 | Presenter: Xiaorong Dong | Author(s): Huijiao Pan, fan Tong, huanhuan Li, Jiaojiao Wang, Chunhua Wei, Hui Lu, ling Peng, ying Wang
- Abstract
Loading... -
+
P2.03-35 - Stromal TIMP-1 Drives Tumor Progression in Lung Adenocarcinoma Through CD63 Interaction
10:15 - 10:15 | Presenter: Paula Duch | Author(s): Marta Gabasa, Rafael Yamashita Ikemori, Frank Hillberg, Noemi Reguart, Jordi Alcaraz
- Abstract
Loading... -
+
P2.03-36 - tTMB and bTMB in East Asian Lung Cancer Patients with No TKI-Related Driver Gene Mutations
10:15 - 10:15 | Presenter: Yayi He | Author(s): Xiaoxia Chen, Bin Chen, Lele Song, Xiaobin Li, Jing Zhang, Lifeng Li, Caicun Zhou
- Abstract
Loading... -
+
P2.03-37 - Genomic Landscape of EGFR/ALK Wild-Type Lung Adenocarcinomas in Never-Smokers and Importance of Epithelial-Mesenchymal-Transition
10:15 - 10:15 | Presenter: Aline Fusco Fares | Author(s): Sebastiao N Martins-Filho, Vibha Raghavan, Erin L Stewart, deepti Ravi, jessica Weiss, Katrina Hueniken, Devalben Patel, Nhu-An Pham, Adrian G Sacher, Penelope A Bradbury, Natasha B Leighl, Frances Shepherd, Ming Sound Tsao, Geoffrey Liu
- Abstract
Loading... -
+
P2.03-38 - Identification of a Novel Synthetic Lethal Vulnerability in Non-Small Cell Lung Cancer by Co-Targeting TMPRSS4 and DDR1
10:15 - 10:15 | Presenter: Esther Redin | Author(s): Maria Villalba, Francisco Exposito, María José Pajares, Cristina Sainz, David Hervas, Elizabeth Guruceaga, Angel Diaz-Lagares, Crsitina Cirauqui, Miriam Redrado, Carlos De Andrea, Eloisa Jantus, Carlos Camps, Rafael López, Agustin Lahoz, Luis M Montuenga, Ruben Pio, Juan Sandoval, Alfonso Calvo
- Abstract
Loading... -
+
P2.03-39 - Systematic Evaluation of EGFR Variant Biology in Cancer
10:15 - 10:15 | Presenter: Tikvah Hayes
- Abstract
Loading... -
+
P2.03-40 - Particle Matters Induce Carcinogenic Phenotype and Gene Expression Changes in Murine Pulmonary Progenitor Cells
10:15 - 10:15 | Presenter: Huei-Wen Chen | Author(s): Tai-Yuan Ling, YU-HSUAN Huang, HSUAN-YU Chen, JEREMY JW Chen, Sheng-Fang Su
- Abstract
Loading... -
+
P2.03-41 - Identification of Novel Blood-Brain Barrier Penetrating DNA Aptamers
10:15 - 10:15 | Presenter: Bo-Tsang Huang | Author(s): Wei-Yun Lai, Yi-Ting Tseng, Chen-EN Yeh, Emily Pei-Ying Lin, Pan-Chyr Yang
- Abstract
Loading... -
+
P2.03-42 - Highly Sensitive Sel-CapTM Lung Cancer Panel NGS for Detection of Tumor-Derived EGFR Mutations in Plasma Cell-Free DNA in Lung Cancer
10:15 - 10:15 | Presenter: Jin Hyoung Kang | Author(s): Jung-Young Shin, Jeong-Oh Kim, Mi-Ran Lee, Min-Young Kim, Han-woo Lee, Hee Kyung Park, Seo Ree Kim, Joori Kim
- Abstract
Loading... -
+
P2.03-43 - WTAP Activates Oncogenes and Accelerates Tumor Aggressiveness Through Adding m6A RNA Modification in Non-Small-Cell Lung Cancer
10:15 - 10:15 | Presenter: Katsuhiro Yoshimura | Author(s): Yusuke Inoue, Kazuo Tsuchiya, Yuji Iwashita, Tomoaki Kahyo, Akikazu Kawase, Masayuki Tanahashi, Yuzo Suzuki, Masato Karayama, Hiroshi Ogawa, Naoki Inui, Kazuhito Funai, Kazuya Shinmura, Hiroshi Niwa, Takafumi Suda, Haruhiko Sugimura
- Abstract
Loading... -
+
P2.03-44 - BLU-667 Demonstrates Robust Activity in RET Fusion-Driven Intracranial Tumor Models
10:15 - 10:15 | Presenter: Erica Evans | Author(s): Wei Hu, Fong Cao, Klaus Hoeflich, Marion Dorsch
- Abstract
Loading... -
+
P2.03-45 - PKCι-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant Adenocarcinoma and Squamous Cell Carcinoma
10:15 - 10:15 | Presenter: Masaoki Ito | Author(s): Carles Codony-Servat, Jordy Codony-Servat, David Llige Santafe, Imane Chaib, Xueting Cai, Peng Cao, Jillian Wilhelmina Paulina Bracht, Morihito Okada, Niki Karachaliou, Rafael Rosell
- Abstract
Loading... -
+
P2.03-46 - PI3K/AKT Signal Pathway Regulates Malignant Transformation of MPLC with EGFR-Sensitive Mutation
10:15 - 10:15 | Presenter: Kewei Ma | Author(s): Yangyang Cai, Xu Wang, Yinghui Xu, Ye Guo, Chao Sun, Shi Qiu
- Abstract
Loading... -
+
P2.03-47 - Deregulation of a Novel Cis-Acting lncRNA in Non-Small Cell Lung Cancer May Control HMGA1 Expression
10:15 - 10:15 | Presenter: Greg L Stewart | Author(s): Adam P Sage, Victor D Martinez, Katey SS Enfield, Wan Lam
- Abstract
Loading... -
+
P2.03-48 - Tumor-Derived Granulocyte Chemotactic Protein 2 Cooperates with Proteases to Drive Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Anne Sophie Lamort | Author(s): Mario Pepe, Ioannis Lilis, Stefanie Anne Weiß, Kristina Anna Maria Arendt, Giannoula Ntaliarda, Μagda Spella, Dieter Jenne, Georgios T Stathopoulos
- Abstract
Loading... -
+
P2.03-49 - Roles of CENPU in Lung Adenocarcinoma Progression and Invasion
10:15 - 10:15 | Presenter: Yuqing Lou | Author(s): Yanwei Zhang, Jianlin Xu, Jun Lu, Xueyan Zhang, Wei Zhang, Huimin Wang, Baohui Han
- Abstract
Loading... -
+
P2.03-50 - Stromal BTK Expression Predicts Poor Prognosis in NSCLC Patients
10:15 - 10:15 | Presenter: Wenhua Liang | Author(s): Minzhang Guo, Jianxing He, Shideng Bao
- Abstract
Loading... -
+
P2.03-51 - Gene Variants and Expressions of Galectin-3 Is Associated with Non Small Cell Lung Cancer and Vascular Invasion of the Tumor
10:15 - 10:15 | Presenter: Akif Turna | Author(s): Sule Terzioglu Usak, Seyda Demirkol, Cem Horozoglu, Dilara Sönmez, İlhan Yaylım
- Abstract
Loading... -
+
P2.03-52 - Correlation Between Inflammatory Markers and Oncological Outcomes in Surgically Resected Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Ryuichi Waseda | Author(s): Naofumi Miyahara, Toshihiko Moroga, Jun-ichi Wakahara, Hideto Mei, Leona Yamamoto, Naoko Imamura, So Miyahara, Takeshi Shiraishi, Akinori Iwasaki
- Abstract
Loading... -
+
P2.03-53 - Immunoproteasome as a Potential Therapeutic Target in Cisplatin-Resistant Small and Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Tetsuaki Shoji | Author(s): Eiki Kikuchi, Junko Kikuchi, Makie Maeda, Yuta Takashima, Megumi Furuta, Hirofumi Takahashi, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Jun Sakakibara-Konishi, Satoshi Konno
- Abstract
Loading... -
+
P2.03-54 - Imprinted Genes Predict Non-Small Cell Lung Cancer Prognosis
10:15 - 10:15 | Presenter: Chunxue Bai | Author(s): Jian Zhou, Tong Cheng, Xing Li, Xiaonan Wang, Han Si, Pengcheng Zhao, Rex C Yung, Rulong Shen, Hongyu Yu, Shaohua Lu, Wenbin Huang, Ning Zhou
- Abstract
Loading... -
+
P2.03-55 - High Integrin α3 Expression Is Associated with Poor Prognosis in Patients with NSCLC
10:15 - 10:15 | Presenter: Weijie Ma | Author(s): Qianping Li, Eddie Tian, Sixi Wei, Shuai Chen, Chihong Zhou, Tao Wang, Tianhong Li
- Abstract
Loading... -
+
P2.03-56 - Polymorphism ICAM-1 and Beta-3 Integrin Are Associated with the Development of Non-Small Cell Lung Cancer and the Prognostic Role of ICAM-1
10:15 - 10:15 | Presenter: Akif Turna | Author(s): Hilal Fındık Kıyan, İlhan Yaylım, Seyda Demirkol, Mehmet Tolgahan Hakan, Ozlem Küçükhüseyin, Ismail Sarbay
- Abstract
Loading... -
+
P2.03-57 - The Role of Arl4c in the Carcinogenesis Process of Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Kenji Kimura | Author(s): Shinji Matsumoto, Eriko Fukui, Takashi Kanou, Naoko Ose, Soichiro Funaki, Yasushi Shintani, Akira Kikuchi
- Abstract
Loading... -
+
P2.03-58 - Double Primary Lung Cancer and Breast Cancer Is a Distinct Disease Entity
10:15 - 10:15 | Presenter: Emily Pei-Ying Lin | Author(s): Pan-Chyr Yang, Yu Shyr
- Abstract
Loading... -
+
P2.03-59 - The Role of Radiation Dose-Dependent Lipid Metabolism Reprogramming on Radiation Survival/Resistance in Lung Cancer Cells
10:15 - 10:15 | Presenter: Xiaoxia Zhu | Author(s): Shangbiao Li, Lijuan Wang, Zhihao Zheng, Xiaotong Duan
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-01 - Changes of BCR Repertoire Are Predictive Biomarker for the Efficacy of Immune Checkpoint Inhibitor in NSCLC
10:15 - 10:15 | Presenter: Koichi Azuma | Author(s): Yoshiro Nakahara, Norikazu Matsuo, Hidenobu Ishii, Takaaki Tokito, kenta Murotani, Tomoaki Hoshino, Tetsuro Sasada
- Abstract
Loading... -
+
P2.04-02 - Effect of Chemotherapy, Chemoimmunotherapy, and Immunotherapy on Parameters of T Cell Exhaustion in Metastatic Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Joshua M Bauml | Author(s): Daniel Yoon, Patrick Yan, Sharyn I Katz, Seth Jeffries, Christiana Davis, Charu Aggarwal, Roger B Cohen, Melina E Marmarelis, Aditi Singh, Christine Ciunci, E. John Wherry, Steven M Albelda, Corey Jay Langer, Alexander C Huang
- Abstract
Loading... -
+
P2.04-03 - Nivolumab Outcomes in Octogenarian Patients with Advanced Non-Small Cell Lung Cancer in French Real-World Setting
10:15 - 10:15 | Presenter: Christos Chouaid | Author(s): Jean-Baptiste Assié, François-Emery Cotté, Matteo Giaj Levra, Christophe Calvet, Ronan Jolivel, Baptiste Jouaneton, Anne-Françoise Gaudin, Valentine Grumberg, Romain Corre
- Abstract
Loading... -
+
P2.04-04 - CITEseq Characterization in Early Stage NSCLC Patients Identifies Distinct Patterns of Immune Infiltrate
10:15 - 10:15 | Presenter: Thomas Urban Marron | Author(s): Andrew Leader, Barbara Maier, John Grout, Christie Chang, Laura Walker, Melanie Davila, Alona Lanksy, Raja Flores, Mary Beth Beasley, Helene Salmon, Adeeb Rahman, Ephraim Kenigsberg, Miriam Merad
- Abstract
Loading... -
+
P2.04-05 - A Retrospective Evaluation of PD-L1 Expression Heterogeneity on Primary Non-Small Cell Lung Cancer and Metastatic Lymph Nodes (REPLICA)
10:15 - 10:15 | Presenter: Andrea Bille | Author(s): Daisuke Nonaka, Philippe Taniere, Elizabeth Willis, Abdel Douiri, Clare Flach, Domenico Curinga, Shriram Velamuri, eleni Karapanagiotou
- Abstract
Loading... -
+
P2.04-06 - Blood-Based Multiplex Kinase Activity Profiling as a Predictive Marker for Clinical Response to Checkpoint Blockade in Advanced NSCLC
10:15 - 10:15 | Presenter: Daan P. Hurkmans | Author(s): Els M.E. Verdegaal, Rik De Wijn, Stijn L.W. Koolen, Cor H.J. Lamers, Dianne M.A. Van Den Heuvel, John P. Groten, Reno Debets, Ellen Kapiteijn, Ron H.J. Mathijssen, Sjoerd H. Van Der Burg, Joachim G.J.V. Aerts
- Abstract
Loading... -
+
P2.04-07 - Surgical Resection of Advanced Lung Cancer After a Response to EGFR-TKI and/or Immunotherapy: A Single Institution Experience
10:15 - 10:15 | Presenter: Domenico Galetta | Author(s): Lorenzo Spaggiari
- Abstract
Loading... -
+
P2.04-08 - Preliminary External Validation of the Clinical Definitions of Resistance to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Erin Alexis Gillaspie | Author(s): Jennifer G. Whisenant, Li-Ching Huang, Megan Wharton, Yu Shyr, Leora Horn
- Abstract
Loading... -
+
P2.04-09 - Immune-Related Adverse Events in Advanced Non-Squamous NSCLC Patients Treated with Upfront Checkpoint Inhibitors Combination
10:15 - 10:15 | Presenter: Kyaw Zin Thein | Author(s): Anita Sultan, Sriman Swarup, Nusrat Jahan, Aung Myint Tun, Srikala Meda, Meily Arevalo, Tun Win Naing, Thura Win Htut, Nicholas D’cunha, Sanjay Awasthi, Shabnam Rehman, Lukman Tijani, Fred Hardwicke
- Abstract
Loading... -
+
P2.04-10 - Biomarkers of Pathological Response on Neo-Adjuvant Chemo-Immunotherapy Treatment for Resectable Stage IIIA NSCLC Patients
10:15 - 10:15 | Presenter: Raquel Laza-Briviesca | Author(s): Alberto Cruz-Bermudez, Marta Casarrubios, Ernest Nadal, Amelia Insa, Rosario Garcia Campelo, Noemi De Dios Alvarez, Manuel Dómine, Margarita Majem, Delvys Rodriguez-Abreu, Virginia Calvo De Juan, Alex Martinez-Marti, Javier De Castro Carpeno, Manuel Cobo, Guillermo López-Vivanco, Elvira Del Barco, Reyes Bernabe, Nuria Viñolas, Isidoro Barneto, Santiago Viteri, Bartomeu Massuti, Mariano Provencio
- Abstract
Loading... -
+
P2.04-11 - Overcoming Resistance to Immunotherapy Using CVA21: Initial Results from a Phase II Study
10:15 - 10:15 | Presenter: Clare Senko | Author(s): Myron Klevansky, Geoffrey Peters, Paul Mitchell, Shane White, Surein Arulananda, Allan Zimet, Khashayar Asadi, Joanna Smith, Noel Micaleff, Jodie Palmer, Teresa Morgan, Oliver Klein, Jonathan Cebon, Tom John
- Abstract
Loading... -
+
P2.04-12 - Ph I Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and SBRT to Multiple Sites in Patients with Stage IV NSCLC
10:15 - 10:15 | Presenter: Jyoti D Patel | Author(s): Michael Jelinek, Christine M Bestvina, Sean Pitroda, Everett E. Vokes, Steve Chmura
- Abstract
Loading... -
+
P2.04-13 - Interleukin-18 and Lung Cancer: A Mendelian Randomization Study
10:15 - 10:15 | Presenter: Jiaqing Liu | Author(s): Huaqiang Zhou, Yaxiong Zhang, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Gang Chen, Shen Zhao, Zhonghan Zhang, Jiayi Shen, Wei Xian, Yan Huang, Hongyun Zhao, Li Zhang
- Abstract
Loading... -
+
P2.04-14 - NLR, dNLR and PLR as Possible Predictive Markers in Patients with NSCLC Treated with ICI
10:15 - 10:15 | Presenter: Tiziana Vavalà | Author(s): Simona Carnio, Annapaola Mariniello, Pamela Pizzutilo, Gianmauro Numico, Gloria Borra, Alice Lunghi, Hector Soto Parra, Roberta Buosi, Ilaria Stura, Silvia Genestroni, Alessandra Alemanni, Francesca Arizio, Annamaria Catino, Michele Montrone, Domenico Galetta, Giuseppe Migliaretti, Silvia Novello
- Abstract
Loading... -
+
P2.04-15 - Association Between Opioids and Outcome of 1st Line Immunotherapy in Advanced NSCLC Patients: A Retrospective Evaluation
10:15 - 10:15 | Presenter: Maristella Bungaro | Author(s): Paolo Bironzo, Daniele Pignataro, Marco Audisio, Marco Tagliamento, Chiara Paratore, Fabrizio Tabbò, Clizia Zichi, Marco De Filippis, Simonetta Grazia Rapetti, valeria Cetoretta, Simona Carnio, Annapaola Mariniello, Lucio Buffoni, Gaetano Lacidogna, Massimo Di Maio, Silvia Novello
- Abstract
Loading... -
+
P2.04-16 - Novel CT Based Radiomic Features are Prognostic and Predictive of Benefit of Chemoimmunotherapy in Advanced Non-Squamous NSCLC
10:15 - 10:15 | Presenter: Kaustav Bera | Author(s): Pradnya Dinkar Patil, Mohammadhadi Khorrami, Alexia Zagouras, Pingfu Fu, Amit Gupta, Vamsidhar Velcheti, Nathan Pennell, Anant Madabhushi
- Abstract
Loading... -
+
P2.04-17 - Immune Repertoire Is a Potential Predictive Biomarker for Evaluating the Efficacy of Mutant Neoantigen Specific T Cell Combined with PD1 Antibody
10:15 - 10:15 | Presenter: Qi Song | Author(s): Jing Li, Tianfu Zhang, Zishan Zhou, Yujie Song, Shengjie Sun, Boyu Qin, Jinliang Wang, Li Zhang, Xiaoling Zhang, Dan Wang, Meiling Chen, Jin Li, Shunchang Jiao
- Abstract
Loading... -
+
P2.04-18 - Analysis of Patient Microbiome and Its Correlation to Immunotherapy Response and Toxicity in Lung Cancer
10:15 - 10:15 | Presenter: Jun Zhang | Author(s): Justin James Chau, Meeta Yadav, Muhammad Furqan, Nicole Cady, Keri Mercer, Evan Eastman, Taher Abu-Hejleh, Gerald Clamon, Shailesh Shahi, Qun Dai, Yousef Zakharia, Rohan Garje, Carlos Chan, George Weiner, Ashutosh Mangalam
- Abstract
Loading... -
+
P2.04-19 - Neoadjuvant Chemotherapy Is Associated with Immunogenic Cell Death and Increased T Cell Infiltration in Early-Stage NSCLC
10:15 - 10:15 | Presenter: Pierre-Olivier Gaudreau | Author(s): Marcelo Vailati Negrao, Kyle Gregory Mitchell, Erin Marie Corsini, Tatiana Karpinets, Qi Wang, Lixia Diao, Jing Wang, Lorenzo Federico, Edwin Parra, Jun Li, Carmen Behrens, Arlene M Correa, Daniel Gomez, Ara A Vaporciyan, Annikka Weissferdt, Hai Tran, Emily Roarty, Ignacio Wistuba, Alexandre Reuben, Cara Haymaker, Chantale Bernatchez, Tina Cascone, John Victor Heymach, Boris Sepesi, Jianjun Zhang, Don Lynn Gibbons
- Abstract
Loading... -
+
P2.04-20 - TP53/KMT2C Co-Mutation as a Novel Biomarker for Immunotherapy in Non-Small Cell Lung Cancer Patients
10:15 - 10:15 | Presenter: Qing Zhou | Author(s): Xiaoxiao Peng, Wenjing Wang, Weifeng Wang, Lin Zhang, Kai Wang, Shiyue Zhang
- Abstract
Loading... -
+
P2.04-21 - Serum CRP Decrease Has Predictive Value for Long-Term Disease Control by PD-1/ PD-L1 Inhibitors in Patients with NSCLC
10:15 - 10:15 | Presenter: Reiko Matsuzawa | Author(s): Masahiro Morise, Ichidai Tanaka, Junji Koyama, Tomoki Kimura, Yasuhiro Kondoh, Tetsunari Hase, Koji Sakamoto, Naozumi Hashimoto, yosinori Hasegawa
- Abstract
Loading... -
+
P2.04-22 - Programmed Death 1-mRNA Expression Predicts Benefit to Anti-PD1 Monotherapy in a Prospective Cohort of Advanced NSCLC
10:15 - 10:15 | Presenter: Cristina Teixido | Author(s): Carlos Cabrera, Adela Rodríguez, Ainara Arcocha, Tomás Pascual, Ana Gimenez-Capitan, Elba Marin, Roxana Reyes, Cristina Aguado, Ana Isabel Martinez-Muñoz, Nuria Viñolas, Blanca Oñate, Daniel Martinez, Miguel Angel Molina-Vila, Aleix Prat, Noemi Reguart
- Abstract
Loading... -
+
P2.04-23 - Tumor-Stroma Interactions Promote cGAS-STING Driven Inflammation in Lung Tumor Microenvironment
10:15 - 10:15 | Presenter: Marco Campisi | Author(s): Shriram Sundararaman, Shunsuke Kitajima, Israel Canadas, Valeria Chiono, Roger Dale Kamm, David Barbie
- Abstract
Loading... -
+
P2.04-24 - Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1
10:15 - 10:15 | Presenter: Justina X Caushi | Author(s): Zhicheng Ji, Jiajia Zhang, Marguerrita El Asmar, Valsamo Anagnostou, Tricia R Cottrell, Hok Yee Chan, Haidan Guo, Taha Merghoub, Jedd D Wolchok, Jarushka Naidoo, Kristen A Marrone, Jamie E. Chaft, Matthew Hellmann, Edward Gabrielson, Janis M Taube, Julie R Brahmer, Victor E Velculescu, Ni Zhao, Patrick M. Forde, Drew M Pardoll, Hongkai Ji, Srinivasan Yegnasubramanian, Kellie Smith
- Abstract
Loading... -
+
P2.04-25 - Gut Mycobiome and Metabolic Interactions with Bacteria in Lung Cancer Patients Reveals Potential Therapeutic Vulnerabilities
10:15 - 10:15 | Presenter: Zoltán Lohinai | Author(s): Rakesh Santhanam, Joshitaro Heshiki, Nagy Dora, Edit Dulka, Gyula Ostoros, Balázs Döme, Sommer Morten, Gianni Panagiotou, Glen J. Weiss
- Abstract
Loading... -
+
P2.04-26 - Single Cell Proteomics Profiling of Live T-Cells in KRAS+ and MET-Amp NSCLC to Predict Immune Checkpoint Inhibitor Response
10:15 - 10:15 | Presenter: Zuan-Fu Lim | Author(s): Xiaoliang Wu, Maria Hafez, Heidar Albandar, Lin Zhu, Haixia Yang, Sean Mackay, Jonathan Chen, Jing Zhou, Patrick C. Ma
- Abstract
Loading... -
+
P2.04-27 - Clinical Implementation of Multiplex Immunofluorescence to Characterize Tumor Immune Status in Lung Cancer Patients
10:15 - 10:15 | Presenter: Lynette M Sholl | Author(s): Evisa Gjini, Kristen Felt, Priti Kumari, James Lindsay, Neal Lindeman, Jonathan Nowak, Ethan Cerami, Scott Rodig
- Abstract
Loading... -
+
P2.04-28 - NeoCOAST: Neoadjuvant Durvalumab Alone or with Novel Agents for Resectable, Early-Stage (I–IIIA) Non‑Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Rosario Garcia Campelo | Author(s): Patrick M. Forde, Walter Weder, Jonathan D. Spicer, Peng He, Oday Hamid, Pablo Martinez, Tina Cascone
- Abstract
Loading... -
+
P2.04-29 - Association of Inflammation Related Genes with Lung Cancer Risk in Moroccan Population
10:15 - 10:15 | Presenter: Houda Kaanane | Author(s): NEZHA Senhaji, HIND Berradi, nadia Benchakroun, Abdellatif Benider, MEHDI Karkouri, HICHAM El Attar, MERIEM Khyatti, SELLAMA Nadifi
- Abstract
Loading... -
+
P2.04-30 - Seq-ing a Better Way to Detect PD-L1 in NSCLC
10:15 - 10:15 | Presenter: Gwyn Bebb | Author(s): Lars Frederick Petersen, Reid McNeil, Michelle L Dean, Angela Chan, Sarah M Orton, Olga Kovalchuk
- Abstract
Loading... -
+
P2.04-31 - Immune Phenotypic Biomarkers in Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation and Atezolizumab
10:15 - 10:15 | Presenter: Steven H Lin | Author(s): Evan N Cohen, Hui Gao, Sanda Tin, Qiong Wu, Jianzhong He, Yawei Qiao, John Victor Heymach, Anne Tsao, James M Reuben
- Abstract
Loading... -
+
P2.04-32 - Comparison of Clinicopathological and Genomic Characteristics Between NSCLCs with a PD-L1 Tumor Proportion Score of ≥90% vs <1%
10:15 - 10:15 | Presenter: Giuseppe Lamberti | Author(s): Yvonne Li, Liam Spurr, Biagio Ricciuti, Gonzalo Recondo Jr., Renato Umeton, Lynette M Sholl, Andrew Cherniak, Mark Awad
- Abstract
Loading... -
+
P2.04-33 - Single-Agent Tislelizumab, an Anti-PD-1 Antibody: Results from a Phase 1 Expansion Cohort in NSCLC Patients
10:15 - 10:15 | Presenter: Andrea Pirzkall | Author(s): Paula Barlow, Michael Jameson, Chia-Chi Lin, John Wu, Jong-Seok Lee
- Abstract
Loading... -
+
P2.04-34 - FCGR2B Expression as a Regulator of Immunity in Non-Small Cell Lung Cancer Patients
10:15 - 10:15 | Presenter: Chung-Yu Chen | Author(s): Ying-Yin Chen, Jin-Yuan Shih, Chong-Jen Yu, Pan-Chyr Yang
- Abstract
Loading... -
+
P2.04-35 - Immune Related Adverse Events in NSCLC Patients Treated with Immune Checkpoint Therapy Who Received the Influenza Vaccination vs No Vaccination
10:15 - 10:15 | Presenter: Haritha G. Reddy | Author(s): Taylor Weis, Shannon Hough, Stephanie Daignault-Newton, Bryan J. Schneider
- Abstract
Loading... -
+
P2.04-36 - Immune Checkpoint Inhibition for Non-Small Cell Lung Cancer (NSCLC) in Patients with Pulmonary Tuberculosis or Hepatitis B
10:15 - 10:15 | Presenter: Gloria Hui Jia Chan | Author(s): Yi Qing Huang, Yvonne LE Ang, Wan Qin Chong, Vaishnavi Muthu, Alvin Seng Cheong Wong, Ross Soo
- Abstract
Loading... -
+
P2.04-37 - Phase I/II Trial of Durvalumab and Tremelimumab with Continuous or Intermittent MEK Inhibitor Selumetinib in Advanced NSCLC
10:15 - 10:15 | Presenter: Pierre-Olivier Gaudreau | Author(s): John Victor Heymach, Don Lynn Gibbons
- Abstract
Loading... -
+
P2.04-38 - Tumor-Associated Neutrophils as a Potential Predictor for Early Recurrence in Resectable I-IIIA Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Xue-Tao Li | Author(s): Mei-Ling Cheng, Jin-Ji Yang, Yi-Long Wu, Xu-Chao Zhang, Jun Hou
- Abstract
Loading... -
+
P2.04-39 - Clinical Characteristics of Long-Term Survivors with Nivolumab in Previously Treated Advanced NSCLC from Real World Data
10:15 - 10:15 | Presenter: Yasutaka Watanabe | Author(s): HIdeaki Mizutani, yasuhiro Kato, Yuki Yamane, Futoshi Kurimoto, Hiroshi Sakai
- Abstract
Loading... -
+
P2.04-40 - Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Yuan Li | Author(s): Zuhua Chen, Long Wu, Weiping Tao
- Abstract
Loading... -
+
P2.04-41 - Clinical and Immunological Factors Associated with Mutation Burden in Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Akira Ono | Author(s): Yukihiro Terada, Mitsuhiro Isaka, Takuya Kawata, Masakuni Serizawa, Takanori Kawabata, Toru Imai, Koji Muramatsu, Isamu Hayashi, Hirotsugu Kenmotsu, Masatoshi Kusuhara, Yasuto Akiyama, Ken Yamaguchi, Takashi Sugino, Yasuhisa Ohde, Toshiaki Takahashi
- Abstract
Loading... -
+
P2.04-42 - PD-L1-Mediated Enhancement of Hexokinase 2 Expression Is Inversely Related to T-Cell Effector Gene Expression in Non-Small-Cell Lung Cancer
10:15 - 10:15 | Presenter: Yoon Kyung Jeon | Author(s): Sehui Kim, Ji-Young Jang, Jaemoon Koh, Dohee Kwon, Young A Kim, Jin Chul Paeng, Chan-Young Ock, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dae Seog Heo, Doo Hyun Chung
- Abstract
Loading... -
+
P2.04-43 - High Occurrence of LINE-1 Retrotransposition Is Correlated with Smoking History, Local Immunosuppression and Poor Prognosis in LUSC
10:15 - 10:15 | Presenter: Jinpu Yu | Author(s): Rui Zhang, Pengpeng Liu, Xiao Zhang, Weijia Zhang
- Abstract
Loading... -
+
P2.04-44 - Combined Immune Checkpoint Blockade in Mesothelioma: In Vivo Investigation of in Vitro Data
10:15 - 10:15 | Presenter: Jan P Van Meerbeeck | Author(s): Elly Marcq, Jonas Van Audenaerde, Jorrit De Waele, Julie Jacobs, Jinthe Van Loenhout, Patrick Pauwels, Evelien LJ Smits
- Abstract
Loading... -
+
P2.04-45 - A Phase 1b Dose-Escalation Study of Carotuximab in Combination with Nivolumab in Patients with Metastatic NSCLC
10:15 - 10:15 | Presenter: Francisco Robert | Author(s): Jhanelle Elaine Gray, Alicia A Trigeiro, Bonne J Adams, Charles Theuer
- Abstract
Loading... -
+
P2.04-46 - Tolerability and Treatment-Related Adverse Events of Upfront Pembrolizumab Combination Regimens in Advanced NSCLC Patients
10:15 - 10:15 | Presenter: Kyaw Zin Thein | Author(s): Nusrat Jahan, Anita Sultan, Sriman Swarup, Francis Mogollon-Duffo, Nimesh Adhikari, Meily Arevalo, Thura Win Htut, Tun Win Naing, Nicholas D’cunha, Shabnam Rehman, Fred Hardwicke, Lukman Tijani
- Abstract
Loading... -
+
P2.04-47 - Tumor Mutational Load, CD8+ T Cells, Expression of PD-L1 and HLA Class I to Guide Immunotherapy Decisions
10:15 - 10:15 | Presenter: Daan P. Hurkmans | Author(s): Merian E. Kuipers, Jasper Smit, Ronald Van Marion, Ron H.J. Mathijssen, Pieter E. Postmus, Pieter S. Hiemstra, Joachim G.J.V. Aerts, Jan H. Von Der Thüsen, Sjoerd H. Van Der Burg
- Abstract
Loading... -
+
P2.04-48 - Use of Immune Checkpoint Inhibitors in Patients with Advanced Lung Cancer and Pre-Existing Autoimmune Diseases
10:15 - 10:15 | Presenter: Samuel Cytryn | Author(s): Elizaveta Efuni, Vamsidhar Velcheti, Sabina Sandigursky
- Abstract
Loading... -
+
P2.04-49 - Nivolumab Plus Ipilimumab (NI) Versus Chemotherapy Plus Nivolumab (CN) in Squamous Cell Lung Cancer (SqCLC): The SQUINT Trial
10:15 - 10:15 | Presenter: Lorenza Landi | Author(s): Laura Bonanno, Angelo Delmonte, Maximilian Papi, Valeria Stati, Vincenzo Minotti, Chiara Bennati, Federica D'Incà, Maria Rita Migliorino, Stefani Gori, Antonio Santo, Francovito Piantedosi, Antonio Russo, Federico Cappuzzo
- Abstract
Loading... -
+
P2.04-50 - Advanced Statistical Approach Tells the Difference: Taylor-Expansion Adjustment for Survival Analyses in Immunotherapy Trials
10:15 - 10:15 | Presenter: Chih-Yuan Hsu | Author(s): Emily Pei-Ying Lin, Yu Shyr
- Abstract
Loading... -
+
P2.04-51 - A 6-Gene Immune Genomic Signature (IGS) Predicts Resistance to Nivolumab [NIV] in Advanced Pretreated NSCLC: Results of PRINCiPe Trial
10:15 - 10:15 | Presenter: Sara Pilotto | Author(s): Vincenzo Di Noia, Isabella Sperduti, Giulia Grizzi, Ettore D'Argento, Michele Simbolo, Caterina Vicentini, Anna Caliò, Andrea Mafficini, Luisa Carbognin, Vincenzo Corbo, Anastasios Gkountakos, Emanuele Vita, Antonio Santo, Matteo Brunelli, Maurizio Martini, Aldo Scarpa, Michele Milella, Giampaolo Tortora, Emilio Bria
- Abstract
Loading... -
+
P2.04-52 - Impact of Corticosteroids and Antibiotics on Efficacy of Immune-Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Mariona Riudavets | Author(s): Joaquin Mosquera, Rosario Garcia Campelo, Jorgina Serra, Georgia Anguera, Pablo Gallardo, Ivana G. Sullivan, Andrés Barba, Margarita Majem
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.04-54 - Characteristic of MSI-H Lung Cancer Patients Identified with Targeted Next-Generation Sequencing
10:15 - 10:15 | Presenter: Rongrong Chen | Author(s): Wen Lin, Yuting Yi, Gen Lin, Jun Zhao, Mingming Yuan, Yan-Fang Guan, Xuefeng Xia
- Abstract
Loading... -
+
P2.04-55 - Tumor Spread Through Air Spaces Is Associated with the Non-Inflamed Immune Microenvironment in Lung Squamous Cell Carcinoma
10:15 - 10:15 | Presenter: Takahiro Karasaki | Author(s): Yukari Kobayashi, Aya Shinozaki-Ushiku, Chihiro Konoeda, Kentaro Kitano, Kazuhiro Nagayama, Masaaki Sato, Akihiro Hosoi, Kazuhiro Kakimi, Jun Nakajima
- Abstract
Loading... -
+
P2.04-56 - Improved Survival of NSCLC Filipino Patients Given Autologous Dendritic Cell Vaccine: Case Series with CTC Upgrade and IL15
10:15 - 10:15 | Presenter: Maria Teresa Alhambra Barzaga | Author(s): Francisco III Maramara Heralde, Nelia Tan-Liu, Mary Suzette Angeles, Samuel Bernal
- Abstract
Loading... -
+
P2.04-57 - Predictive and Prognostic Value of CTC Monitoring in Advanced NSCLC Patients Treated with Immune Checkpoint Inhibitors
10:15 - 10:15 | Presenter: Guanghui Gao | Author(s): Jiayu Li, Fei Zhou, Wei Li, Anwen Xiong, Xiaoxia Chen, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P2.04-58 - The Correlation Between TMB and Clinical Factors in East Asian Lung Cancer Patients with No TKI-Related Driver Gene-Mutations
10:15 - 10:15 | Presenter: Yayi He | Author(s): Xiaoxia Chen, Bin Chen, Lele Song, Xiaobin Li, Caicun Zhou
- Abstract
Loading... -
+
P2.04-59 - Patient Survival in NSCLC Based on PDL1 Expression and Tissue Origin
10:15 - 10:15 | Presenter: Sam Khan | Author(s): Maria Charalambous, Mariam Khan, Fariah Khalid, Muqeet Enver, Samreen Ahmed
- Abstract
Loading... -
+
P2.04-60 - Pembrolizumab-Based Regimens Administered at Non-Standard Frequency in Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Kartik Sehgal | Author(s): Meghan Shea, Danielle C. McDonald, Mark Huberman, Glen J Weiss, Paul A. Vanderlaan, Daniel B Costa, Deepa Rangachari
- Abstract
Loading... -
+
P2.04-61 - Preliminary Report of a Multidisciplinary Task Group for the Study of Immune-Mediated Pulmonary Toxicity
10:15 - 10:15 | Presenter: Roberto Martin-Deleon | Author(s): Marcelo Sanchez, Mariana Benegas, Carmen Mª Lucena, Carlos Cabrera, Roxana Reyes, Daniel Martinez, Jose Ramirez, Ramon Mª Marrades, Nuria Viñolas, Cristina Teixido, Carlos Agusti, Noemi Reguart, Jacobo Sellares
- Abstract
Loading... -
+
P2.04-62 - TCR Repertoire Analysis of Peripheral CD8+PD-1+ T Cells Is Effective as a Predictive Biomarker for Response to the Immune Checkpoint Inhibitor
10:15 - 10:15 | Presenter: Seiji Matsumoto | Author(s): Takaji Matsutani, Yoshiko Fujita, Kazutaka Kitaura, Yukio Nakamura, Toru Nakamichi, Akifumi Nakamura, Ayumi Kuroda, Masaki Hashimoto, Nobuyuki Kondo, Tadasu Shini, Ryuji Suzuki, Seiki Hasegawa
- Abstract
Loading... -
+
P2.04-63 - Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Hayat Oum El Kheir Ramdani | Author(s): Markus Falk, Stefanie Schatz, Markus Tiemann, Lukas C Heukamp, Ed Schuuring, Harry JM Groen, Frank Griesinger
- Abstract
Loading... -
+
P2.04-64 - 222 NSCLC’s Classified by PAM50: Luminal A NSCLC Is a Distinct Subtype with Low TMB and Immune Suppressive TME
10:15 - 10:15 | Presenter: Hossein Borghaei | Author(s): Sandeep Reddy, Christopher Szeto
- Abstract
Loading... -
+
P2.04-65 - Peptide-Based Cancer Vaccine Shortened the Overall Survival of a Large Portion, but Not All, of Advanced Cancer Patients
10:15 - 10:15 | Presenter: Koichi Yoshiyama | Author(s): Masanori Noguchi, Mizuhiko Terasaki, Shunichi Sugawara, Akira Yamada, Shigeki Shichijo, Shinzo Takamori, Yoshito Akagi, Shigeru Yutani, Kyogo Itoh
- Abstract
Loading... -
+
P2.04-66 - Immunotherapy for All? Representation of Minorities and the Elderly in Lung Cancer Immunotherapy Trials
10:15 - 10:15 | Presenter: Ana I Velazquez | Author(s): Leslie Seijo, Narjust Duma
- Abstract
Loading... -
+
P2.04-67 - Comparative Analysis of TMB and Mutations by Comprehensive Genomic Profiling (TSO500) in FFPE NSCLC Samples
10:15 - 10:15 | Presenter: Johan Botling | Author(s): Helena Nord, Agnes Soderberg, Patrick Micke, Johan Isaksson, Patrik Smeds, Lotte Moens
- Abstract
Loading... -
+
P2.04-68 - Retrospective Analysis of Immune Checkpoint Inhibitors in NSCLC: Immune-Related Adverse Events and Outcomes
10:15 - 10:15 | Presenter: Alvin Jun Xing Lee | Author(s): Michael K Luong, Danielle Ohana, Martin David Forster, Siow Ming Lee
- Abstract
Loading... -
+
P2.04-69 - Impact of Antibiotic Usage on Survival During Checkpoint Inhibitor Treatment of Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Mary Jo Fidler | Author(s): Cory Hogue, Timothy Kuzel, Jeffrey Allen Borgia, Gaurav Marwaha, Philip Bonomi, Marta Batus, Dian Wang, Parul Barry
- Abstract
Loading... -
+
P2.04-70 - PD-L1 Expression in a Population with Non-Small Cell Lung Cancer in a Reference Healthcare Center in Latin-America
10:15 - 10:15 | Presenter: Liliana Fernandez-Trujillo | Author(s): Luz Fernanda Sua, Juliana Lores, Marisol Aguirre
- Abstract
Loading... -
+
P2.04-71 - Bullous Pemphigoid: A Rare Immunomediated Event Secondary to Immunotherapy in a Patient with Metastatic Lung Cancer
10:15 - 10:15 | Presenter: Eduardo de Figueiredo Vissotto | Author(s): Gabriella Oliveira Mendes
- Abstract
Loading... -
+
P2.04-72 - Clinical Feature and Management of Acquired Resistance to PD-1 Inhibitor in Advanced NSCLC
10:15 - 10:15 | Presenter: Sachi Okawa | Author(s): Hibiki Udagawa, Tomoyuki Naito, Keisuke Kirita, Takaya Ikeda, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Koichi Goto
- Abstract
Loading... -
+
P2.04-73 - Maintenance Treatment Using CimaVax EGF Vaccine. Experience of Single Institution
10:15 - 10:15 | Presenter: Yoanna Flores | Author(s): Diana Laura Páramo, Sofía Alsina, Luis Enrique Alsina, Iris Inguanzo, Jorge Rodríguez, Angel Elejalde, Elpidio Flores, Janet Lamadrid, Danay Corrales, Ramón Ropero, Elías Antonio Gracia, Grober Gondori
- Abstract
Loading... -
+
P2.04-74 - Radiotherapy Prior to Immunotherapy Is Associated with Durable Disease Control in Advanced NSCLC
10:15 - 10:15 | Presenter: Åsa Kristina Öjlert | Author(s): Marius Lund-Iversen, Renée Åstrøm Ellefsen, Mette Sprauten, Odd Terje Brustugun, Vidar Flote, Ann Rita Halvorsen, Åslaug Helland
- Abstract
Loading... -
+
P2.04-75 - Overall Survival by IDO1 and PD-L1 Expression in NSCLC Patients Receiving an Immune Checkpoint Inhibitor (ICI)
10:15 - 10:15 | Presenter: Richard D Hall | Author(s): Margaret Moore, Erin Marie McLoughlin, John W Melson, Bethany Horton, Anne M Mills, Ryan D Gentzler
- Abstract
Loading... -
+
P2.04-76 - Tumor Mutational Burden by TSO500 Next Generation Sequencing Panel and Clinical Outcome in Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Kristof Cuppens | Author(s): Guy Froyen, Bert Cruys, Ellen Geerdens, Ruth Achten, Michel Vanbockrijck, Brigitte Maes
- Abstract
Loading... -
+
P2.04-77 - Hyperprogression with Immunotherapy in Metastatic Non-Small Cell Lung Cancer: Hôpital Charles-LeMoyne Experience
10:15 - 10:15 | Presenter: Luisa Galvis Gomez | Author(s): Diego Gonzalez, Benoit Samson, Flavia De Angelis
- Abstract
Loading... -
+
P2.04-78 - PD-L1 Expression as a Prognostic Marker for Non-Small Cell Lung Cancer in Distinct Mutational Status
10:15 - 10:15 | Presenter: Narumol Trachu | Author(s): Songporn Oranratnachai, Nareenart Iemwimangsa, Pimpin Incharoen, Supoj Detarkom, Pimtip Sanvarinda, Wasun Chantratita, Thanyanan Reungwetwattana
- Abstract
Loading... -
+
P2.04-79 - High Rate of Immune Related Pneumonitis in Lung Cancer Patients Treated with Anti PD-1 Antibodies
10:15 - 10:15 | Presenter: Andrés Aguilar Hernandez | Author(s): Juan Jose Garcia Mosquera, Santiago Viteri, Maria Joao Araujo, Jillian Wilhelmina Paulina Bracht, Carmen Cambray, Ernest Belmonte, Felipe Coll-Klein, Fabiana Letizia Cecere, Miguel Angel Molina-Vila, Francesc Tresserra, Maria Gonzalez-Cao, Rafael Rosell
- Abstract
Loading... -
+
P2.04-80 - Pretreatment Nutritional Status and Response to Checkpoint Inhibitors in Lung Cancer
10:15 - 10:15 | Presenter: Nagashree Seetharamu | Author(s): Chung-Shien Lee, Rebecca Sin, Craig Devoe, Xinhua Zhu, Mee-Young Lee
- Abstract
Loading... -
+
P2.04-81 - Non-Small Cell Lung Cancer Treated with Immunotherapy: Multi-Institutional Experience from Argentina
10:15 - 10:15 | Presenter: Manglio Miguel Rizzo | Author(s): Maria Virginia Bluthgen, Gonzalo Recondo Jr., Martin Naveira, Aldo Agustin Perfetti, Maria Florencia Rizzi, Matías Alejandro Cerini, Alejandro Daniel Kuzminin, Maria Victoria Faura, Carlos Silva, Lorena Lupinacci, Nicolás Minatta
- Abstract
Loading... -
+
P2.04-82 - Discontinuation of Anti-PD-1/PD-L1 Antibody Therapy in the Absence of Disease Progression: Clinical Outcomes in Advanced NSCLC
10:15 - 10:15 | Presenter: Nicolás Minatta | Author(s): Maria Virginia Bluthgen, Manglio Miguel Rizzo, Maria Florencia Rizzi, Alejandro Daniel Kuzminin, Gonzalo Recondo Jr., Maria Victoria Faura, Martin Naveira, Aldo Agustin Perfetti, Matías Alejandro Cerini, Lorena Lupinacci
- Abstract
Loading... -
+
P2.04-83 - Long-Term Follow-Up Compassionate Use Program Nivolumab in NSCLC
10:15 - 10:15 | Presenter: Paul Baas | Author(s): Robert Schouten, Mirte Muller, Erik Van Werkhoven
- Abstract
Loading... -
+
P2.04-84 - NSCLC Survival Expectancy for Patients Treated with Docetaxel/Nintedanib in the SENECA Trial and Previous Immunotherapy
10:15 - 10:15 | Presenter: Enrica Capelletto | Author(s): Giorgia Osman, Alessandro Morabito, Rita Chiari, Francesco Grossi, marcello Tiseo, Francesco Di Costanzo, Angelo Delmonte, Gianpiero Romano, Andrea Misino, Vieri Scotti, Vanesa Gregorc, Salvatore Pisconti, Maria Bonomi, Alessandro Del Conte, Libero Ciuffreda, Ida Colantonio, Emilio Bria, Serena Ricciardi, Anna Manzo, Giulio Metro, Anna Maria Morelli, Rossana Critelli, Ilaria Stura, Giuseppe Migliaretti, Silvia Novello
- Abstract
Loading... -
+
P2.04-85 - Clinical Significance of the PD-L2 Expression in Patients with NSCLC Receiving Anti-PD-1 Inhibitors
10:15 - 10:15 | Presenter: Hidenobu Ishii | Author(s): Koichi Azuma, Norikazu Matsuo, Takaaki Tokito, Kazuhiko Yamada, Tomoaki Hoshino
- Abstract
Loading... -
+
P2.04-86 - Efficacy of Ipilimumab in Combination with Chemotherapy for First-Line Treatment of Advanced Lung Cancer
10:15 - 10:15 | Presenter: Kyaw Zin Thein | Author(s): Thura Win Htut, Aung Myint Tun, Sriman Swarup, Anita Sultan, Francis Mogollon-Duffo, Nusrat Jahan, Nimesh Adhikari, Yadana Oo, Aye Mon Thida, Htun Min Aung, Wai Phyo Thi, Kalpana Panigrahi, Lukman Tijani
- Abstract
Loading... -
+
P2.04-87 - Efficacy of Immune Checkpoint Inhibitors for Locally Advanced Non-Small Cell Lung Cancer Patients Before Durvalumab Approval
10:15 - 10:15 | Presenter: Tomoya Fukui | Author(s): Shinji Hosotani, Itaru Soda, Hiromichi Ishiyama, Mikiko Ishihara, Masashi Kasajima, Yasuhiro Hiyoshi, Satoshi Igawa, Sasato Katagiri, Katsuhiko Naoki
- Abstract
Loading... -
+
P2.04-88 - Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial
10:15 - 10:15 | Presenter: Jay M Lee | Author(s): Jamie E. Chaft, Alan Nicholas, G Alec Patterson, Saiama Waqar, ERIC M Toloza, Eric B Haura, DAN J Raz, Karen L Reckamp, ROBERT E Merritt, Dwight Hall Owen, DAVID J Finley, CIARAN J McNamee, Justin D Blasberg, Edward Garon, JOHN D Mitchell, Robert C. Doebele, FRANK A Baciewicz, Misako Nagasaka, Harvey I Pass, Ann Johnson, See-Chun Phan, Katja Schulze, Paul A Bunn, Jr, Bruce E Johnson, Mark G Kris, David J Kwiatkowski, Ignacio Wistuba, David P Carbone, Valerie W. Rusch
- Abstract
Loading... -
+
P2.04-89 - Neoadjuvant Pembrolizumab in Early Stage Non-Small Cell Lung Cancer (NSCLC): Toxicity, Efficacy, and Surgical Outcomes
10:15 - 10:15 | Presenter: Neal Ready | Author(s): Betty C Tong, Jeffrey Clarke, Lin Gu, Dennis Wigle, Konstantin H Dragnev, Thomas Sporn, Thomas Stinchcombe, Thomas A D’amico
- Abstract
Loading... -
+
P2.04-90 - Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Boris Sepesi | Author(s): Myrna C. B. Godoy, William N. William, Ara A Vaporciyan, Heather Lin, Cheuk Leung, Jack Lee, Kyle Gregory Mitchell, Annikka Weissferdt, Xiuning Le, Vincent Lam, Frank Fossella, Stephen Swisher, John Victor Heymach, Tina Cascone
- Abstract
Loading... -
+
P2.04-91 - Target Antigen Levels in NSCLC Define a Clinically Relevant Activation Threshold for NY-ESO-1c259 TCR T-Cell Therapy
10:15 - 10:15 | Presenter: Anna Domogala | Author(s): Ioanna Eleftheriadou, Sara Brett, Lea Patasic, Magdalena Anna Kijewska, Katrina Soor, Junping Jing, Jack Euesden, Kurt R Auger, Ryan Roberts, Sylvia O'Sullivan, Laura Castelletti, Miriam Damm, Jan Klapwijk, John R Spaull, Dmitry Pankov, Laura Alexandra Johnsons, Aiman Shalabi, Cedrik Britten
- Abstract
Loading... -
+
P2.04-92 - Neoadjuvant Durvalumab With or Without Sub-Ablative Stereotactic Radiotherapy (SBRT) in Patients with Resectable NSCLC (NCT02904954)
10:15 - 10:15 | Presenter: Nasser K Altorki | Author(s): Alain Borczuk, Ashish Saxena, Jeffrey L Port, Brendon M Stiles, Benjamin Lee, Nicholas J Sanfilippo, Eric Ko, Ronald J Scheff, Bradley B Pua, James F Gruden, Paul J Christos, Cathy Spinelli, Joyce Gakuria, Vivek Mittal, Tim McGraw, Silvia C Formenti
- Abstract
Loading... -
+
P2.04-93 - Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: W. Jeffrey Petty | Author(s): Tamjeed Ahmed, Thomas Lycan, Payal Gandhi, Jennifer Miller, Beverly Levine, Michael Farris, Jimmy Ruiz
- Abstract
Loading... -
+
P2.04-94 - PD-L1 Expression in Uncommon EGFR-Mutant Non-Small Cell Lung Cancer and Its Response to Immunotherapy
10:15 - 10:15 | Presenter: Yun Fan | Author(s): kaiyan Chen
- Abstract
Loading...